Compound_CID,Name,Synonyms,Molecular_Weight,Molecular_Formula,Polar_Area,Complexity,XLogP,Heavy_Atom_Count,H-Bond_Donor_Count,H-Bond_Acceptor_Count,Rotatable_Bond_Count,InChI,SMILES,InChIKey,IUPAC_Name,Exact_Mass,Monoisotopic_Mass,Charge,Covalent_Unit_Count,Isotopic_Atom_Count,Total_Atom_Stereo_Count,Defined_Atom_Stereo_Count,Undefined_Atom_Stereo_Count,Total_Bond_Stereo_Count,Defined_Bond_Stereo_Count,Undefined_Bond_Stereo_Count,Linked_PubChem_Literature_Count,Linked_PubChem_Patent_Count,Linked_PubChem_Patent_Family_Count,MeSH_Headings,Annotation_Content,Annotation_Type_Count,Linked_BioAssays,Create_Date,Data_Source,Data_Source_Category,Tagged_by_PubChem
10184653,Afatinib,"Afatinib|439081-18-2|850140-72-6|Tovok|BIBW2992|Tomtovok|BIBW 2992|BIBW-2992|(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|Afatinib (BIBW2992)|(E/Z)-Afatinib|afatinibum|BIBW2992 (Tovok)|Afatinib free base|NSC-750691|UNII-41UD74L59M|(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|CHEBI:61390|41UD74L59M|N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|CHEMBL1173655|DTXSID20893451|850140-72-6 (free base)|NSC750691|(2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|S1011|AFATINIB (MART.)|AFATINIB [MART.]|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-|MFCD12407405|(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide.|(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|Afatinib [USAN]|Afatinib, Free Base|Afatinib [USAN:INN]|Afatinib E-Isomer|(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((3S)-tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide; BIBW 2992;|(E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl)-amide|(E)-4-Dimethylamino-but-2-enoic acid-[4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl]-amide|BIBW2992,Afatinib|Afatinib (USAN/INN)|AFATINIB [INN]|AFATINIB [MI]|AFATINIB [VANDF]|AFATINIB [WHO-DD]|(E/Z)-Afatinib (Standard)|Afatinib - Bio-X trade mark|MLS006010000|EX-A065A|GTPL5667|CHEBI:94698|EX-A065|L01XE13|ULXXDDBFHOBEHA-CWDCEQMOSA-N|BCPP000338|DTXCID301323466|HY-10261BR|BCP01779|BDBM50322823|HY-10261B|NSC799327|Afatinib(cis-trans isomerismtautomers)|AKOS015850681|AKOS015904219|AKOS025149636|BCP9000407|CCG-264776|DB08916|EX-8656|FC17230|NSC-799327|SDCCGSBI-0654325.P001|NCGC00185000-01|NCGC00185000-22|NCGC00185000-23|(E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide|2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-|AC-26079|AC-27018|AS-80916|BA164141|DS-14172|SMR004701084|A2870|CS-0020030|NS00077621|SW219248-1|D09724|AB01565886_02|EN300-6487482|EN300-19625328|SR-01000941576|Q4688818|SR-01000941576-1|BRD-K66175015-001-01-7|BRD-K66175015-001-09-0|BRD-K66175015-001-13-2|BRD-K66175015-332-01-6|Z2568727518|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;BIBW 29    92|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;BIBW 29 92|(E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6yl)-amide|(S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide",485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,ULXXDDBFHOBEHA-CWDCEQMOSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.1629955,485.1629955,0,1,0,1,1,0,1,1,0,4117,33199,6987,Afatinib,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|410943|410944|492109|492110|492111|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|624891|624892|624893|624894|624895|624896|624897|624898|624899|624900|624901|624902|624903|624904|624905|624906|624907|624908|624909|624910|624911|624912|624913|624914|624915|624916|624917|624918|624919|624920|624921|624922|624923|624924|624925|624926|624927|624928|624929|624930|624931|624932|624933|624934|624935|624936|624937|624938|624939|624940|624941|624942|624943|624944|624945|624946|624947|624948|624949|624950|624951|624952|624953|624954|624955|624956|624957|624958|624959|624960|624961|624962|624963|624964|624965|624966|624967|624968|624969|624970|624971|624972|624973|624974|624975|624976|624977|624978|624979|624980|624981|624982|624983|624984|624985|624986|624987|624988|624989|624990|624991|624992|624993|624994|624995|624996|624997|624998|624999|625000|625001|625002|625003|625004|625005|625006|625007|625008|625009|625010|625011|625012|625013|625014|625015|625016|625017|625018|625019|625020|625021|625022|625023|625024|625025|625026|625027|625028|625029|625030|625031|625032|625033|625034|625035|625036|625037|625038|625039|625040|625041|625042|625043|625044|625045|625046|625047|625048|625049|625050|625051|625052|625053|625054|625055|625056|625057|625058|625059|625060|625061|625062|625063|625064|625065|625066|625067|625068|625069|625070|625071|625072|625073|625074|625075|625076|625077|625078|625079|625080|625081|625082|625083|625084|625085|625086|625087|625088|625089|625090|625091|625092|625093|625094|625095|625096|625097|625098|625099|625100|625101|625102|625103|625104|625105|625106|625107|625108|625109|625110|625111|625112|625113|625114|625115|625116|625117|625118|625119|625120|625121|625122|625123|625124|625125|625126|625127|625128|625129|625130|625131|625132|625133|625134|625135|625136|625137|625138|625139|625140|625141|625142|625143|708781|708783|718821|718822|718823|719885|719887|729594|729977|729978|741697|741698|741699|741701|741702|741703|741704|741705|741706|741708|741710|741711|741712|741713|741714|741718|741719|741720|741721|741722|741723|741725|741726|741728|741729|741731|741735|741736|741737|741738|741739|741740|741741|741742|741744|741745|741748|741750|741751|741752|741753|741754|741757|741758|741759|741761|741762|741763|741766|741767|741768|741770|741771|741774|741775|741777|741778|741779|741780|741781|741782|741783|741784|741785|741786|741787|741788|741789|741790|741791|741792|741793|741794|741795|741797|741798|741799|741800|741801|741802|741803|741805|741806|741807|741808|741809|741810|741812|741814|741815|741816|741817|741818|741820|741821|741822|741823|741826|741827|741828|741830|741831|741833|741834|741835|741837|741838|741840|741841|741842|741843|741844|741845|741846|741848|741849|741850|741852|741853|741854|741855|741856|741857|741860|741861|741863|741864|741865|741866|741867|741868|741869|741870|741871|741873|741876|741877|741878|741879|741880|741881|741882|741883|741885|741886|741888|741889|741890|741893|741898|741899|741900|741901|741902|741903|741904|741905|741906|741907|741908|741909|741910|741911|741912|741913|741914|741915|741916|741917|741918|741919|741920|741921|741922|741923|741924|741925|741928|741929|741930|741931|741932|741933|741934|741935|741936|741937|741938|741939|741940|741941|741942|741943|741944|741946|741947|741948|741949|741950|741951|741952|741953|741954|741955|741956|741957|741958|741959|741960|741961|741962|741963|741965|741966|741967|741968|741969|741970|741971|741974|741975|741976|741977|741978|741979|741980|741984|741985|741986|741987|741988|741989|741990|741991|741993|741994|741995|741996|741998|741999|742000|742002|742003|742004|742005|742006|742007|742008|742009|742010|742011|742012|742015|742016|742017|742018|742019|742020|742021|742024|742025|742028|742029|742030|742031|742033|742034|742035|742036|742037|742039|742040|742041|742042|742043|742044|742045|742047|742048|742049|742051|742052|742053|742054|742055|742056|742058|742060|742061|742062|742065|742068|742069|742070|742071|742072|742073|742074|742075|742076|742077|742078|742079|742080|742082|742083|742084|742088|742089|742090|742091|742092|742093|742095|742096|742099|742100|742101|742102|742103|742104|742105|742106|742107|742108|742109|742110|742111|742112|742114|742115|742116|742118|742120|742121|742122|742123|742124|742125|742127|742129|742130|742133|742134|742138|742139|742140|742141|742143|742144|742145|742146|742147|742148|742149|742150|742151|742152|742153|742154|742156|742157|742159|742160|742161|742162|742163|742164|742166|742167|742168|742169|742170|742171|742172|742173|742174|742175|742176|742178|742179|742180|742181|742182|742183|742184|742185|742186|742187|742188|742189|742191|742192|742193|742194|742196|742197|742198|742200|742201|742202|742203|742204|742205|742206|742207|742208|742209|742210|742211|742212|742213|742214|742215|742216|742217|742218|742219|742220|742221|742222|742223|742224|742225|742226|742227|742228|742229|742230|742231|742232|742233|742234|742235|742236|742237|742238|742239|742240|742241|742242|742243|742244|742245|742249|742250|742251|742253|742254|742255|742256|742257|742258|742260|742262|742263|742264|742266|742267|742268|742269|742270|742271|742272|742273|742274|742275|742277|742278|742279|742280|742281|742283|742284|742285|742286|742287|742288|742289|742290|742291|742292|742293|742294|742295|742296|742297|742298|742299|742300|742302|742303|742304|742305|742306|742307|742309|742310|742313|742315|742316|742317|742318|742319|742321|742323|742324|742325|742326|742327|742328|742329|742331|742332|742333|742334|742335|742336|742338|742339|742340|742342|742343|742344|742345|742346|742347|742349|742350|742351|742352|742354|742356|742357|742358|742360|742361|742362|742363|742364|742365|742366|742367|742368|742369|742370|742371|742372|742373|742374|742376|742378|742379|742380|742381|742382|742383|742384|742388|742389|742390|742391|742392|742393|742394|742395|742396|742397|742399|742400|742401|742403|742404|742405|742406|742409|770073|770078|770079|770080|770081|770082|770083|1057928|1057929|1057934|1057935|1128564|1128565|1128566|1128567|1128589|1128590|1137579|1137580|1137581|1137582|1137583|1137584|1137585|1137586|1137587|1137601|1137602|1159387|1159388|1167145|1167147|1167156|1167158|1167177|1167178|1167179|1167180|1171417|1171418|1171419|1171420|1171421|1171435|1171436|1171437|1171438|1171439|1171445|1171447|1171449|1171451|1171453|1171455|1171456|1171460|1171461|1175323|1175324|1176840|1176841|1239424|1250263|1250264|1250285|1250286|1250287|1250288|1250289|1250290|1250291|1250366|1250367|1250368|1250369|1250370|1250371|1250372|1250373|1259251|1259398|1259399|1259416|1259421|1259423|1279096|1279097|1279098|1279099|1279100|1279101|1301834|1301835|1301836|1301837|1301838|1301839|1301840|1321117|1321118|1321122|1321123|1321125|1341757|1341761|1341762|1345502|1345653|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347162|1347411|1347412|1365584|1365585|1365586|1368035|1368036|1409092|1409093|1409605|1420982|1420983|1420984|1420985|1420986|1421403|1421405|1421406|1421409|1421411|1421413|1421415|1421417|1421419|1421420|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424952|1424953|1424954|1424955|1424956|1424957|1424958|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424988|1424989|1424990|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425005|1425006|1425007|1425008|1425009|1425010|1425011|1425013|1425014|1425015|1425016|1425017|1425018|1425019|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425031|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425076|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1,20061025,"001Chemical|10X CHEM|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Accel Scientific|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acmec Biochemical|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|AppChem|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BePharm Ltd.|Bic Biotech|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|Chemical Probes Portal|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|Elsa Biotechnology|eMolecules|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Fisher Drug Discovery Resource Center|Founder Pharma|GlyTouCan Project|Google Patents|Hangzhou APIChem Technology|Hunan Huateng Pharmaceutical Co., Ltd.|iChemical Technology USA Inc|InvivoChem|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|Matrix Scientific|Mcule|MedChemexpress MCE|Metabolomics Workbench|MLSMR|Molecular Pharmacology Branch, DTP, NCI|Molepedia|MolGenie|Molport|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|Oakwood Products|OChem|OXCHEM CORPORATION|Paragos|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|PubChem Reference Collection|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Syntree|TargetMol|TCI (Tokyo Chemical Industry)|Tenova Pharmaceuticals Inc|THE BioTek|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tocris Bioscience|ToxPlanet|Tractus|Uchem Meditech|UCSC Chemical Screening Center|Up-Fluorochem|VladaChem|Wikidata|Win-Win Chemical|Wubei-Biochem|Wutech|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
7443,"1,2-Dichloro-4-nitrobenzene","3,4-DICHLORONITROBENZENE|1,2-Dichloro-4-nitrobenzene|99-54-7|1-Nitro-3,4-dichlorobenzene|Benzene, 1,2-dichloro-4-nitro-|DCNB|3,4-Dichlornitrobenzen|CCRIS 3097|1,2-Dichloro-4-nitro-benzene|3,4-Dichloronitrobenzen|3,4-Dichlornitrobenzen [Czech]|HSDB 4252|3,4-Dichloronitrobenzen [Czech]|UNII-IJT74JI7FS|IJT74JI7FS|NSC 6295|AI3-03268 (USDA)|EINECS 202-764-2|BRN 1818163|DTXSID8024999|AI3-03268|NSC-6295|NSC-99806|3,4-dichloro-1-nitrobenzene|DTXCID504999|EC 202-764-2|3,4-DICHLORONITROBENZENE [HSDB]|WLN: WNR CG DG|Benzene,2-dichloro-4-nitro-|CAS-99-54-7|3,4-DICHLORONITROBENZEN (CZECH)|1,2-Dichloro-4-nitrobenzene; 1-Nitro-3,4-dichlorobenzene; 3,4-Dichloronitrobenzene; DCNB; NSC 6295; NSC 99806|3,4Dichlornitrobenzen|3,4Dichloronitrobenzen|1,2Dichloro4nitrobenzene|1Nitro3,4dichlorobenzene|3, 4-dichloronitrobenzene|3,4-dichloro-nitrobenzene|3,4-dichloro-nitro benzene|Benzene, 1,2dichloro4nitro|SCHEMBL85918|3,4-dichloro- 1-nitrobenzene|CHEMBL167468|NSC6295|AI303268 (USDA)|NSC99806|STR01633|Tox21_201613|Tox21_300293|MFCD00007207|STL256829|1,2-Dichloro-4-nitrobenzene, 99%|AKOS005157643|FD70434|3,4-Dichloronitrobenzene ; 3,4-DCNB|NCGC00091637-01|NCGC00091637-02|NCGC00091637-03|NCGC00091637-04|NCGC00254103-01|NCGC00259162-01|DB-003354|CS-0164308|D0388|NS00010037|EN300-54305|A19495|E78961|Q2469366|1,2-dichloro-4-nitrobenzene? (Afatinib Impurity pound(c)|1,2-Dichloro-4-nitrobenzene, PESTANAL(R), analytical standard",192.000,C6H3Cl2NO2,45.800,159.000,3.100,11,0,2,0,InChI=1S/C6H3Cl2NO2/c7-5-2-1-4(9(10)11)3-6(5)8/h1-3H,C1=CC(=C(C=C1[N+](=O)[O-])Cl)Cl,NTBYINQTYWZXLH-UHFFFAOYSA-N,"1,2-dichloro-4-nitrobenzene",190.9540837,190.9540837,0,1,0,0,0,0,0,0,0,431,1514,618,"",Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,15,155|157|161|165|167|175|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1948|2101|2107|2112|2120|2517|2546|2549|2551|23442|200691|485290|588453|588456|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|588579|588590|588795|588834|589006|624178|624202|624263|624414|651631|651632|651633|651634|651741|651743|651749|651751|651754|651755|651757|651758|651777|651778|651802|651838|651965|652106|686970|686971|686978|686979|720516|720552|720579|720580|720634|720635|720636|720637|720652|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743288|743292|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259401|1259402|1259403|1259404|1259407|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347041|1347395|1347397|1347398|1347399|1524436|1671196|1671197|1671198|1671199|1671200|1671201|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1919968|1919969|1919970|1920063|1920064|1920065|1920067|1920068|1963577|1963578|1963579|1963580|1963581|1963582|1963583|1963584|1963585,20050326,"001Chemical|10X CHEM|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|ACT Chemical|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Aladdin Scientific|Amadis Chemical|AN PharmaTech|Angene Chemical|Anward|AppChem|Aromalake Chemical|Aromsyn catalogue|Aronis|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Baker Lab, Chemistry Department, The University of North Carolina at Chapel Hill|BenchChem|BePharm Ltd.|Bic Biotech|Biocore|Biosynth|CAPOT|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemical Carcinogenesis Research Information System (CCRIS)|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemTik|Clearsynth|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Crystallography Open Database (COD)|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|DSL Chemicals|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|Enamine|enviPath|EPA DSSTox|EPA Substance Registry Services|FDA Global Substance Registration System (GSRS)|Founder Pharma|Google Patents|Hairui Chemical|Halochem|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|Kingston Chemistry|LeadScope|LGC Standards|Mcule|MolCore|Molecule Market|Molepedia|MolGenie|Molport|MP Biomedicals|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIST Chemistry WebBook|NIST Mass Spectrometry Data Center|NMRShiftDB|NORMAN Suspect List Exchange|NovoSeek|Oakwood Products|OtavaChemicals|OXCHEM CORPORATION|Parchem|PATENTSCOPE (WIPO)|Pi Chemicals|PubChem Reference Collection|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Sigma-Aldrich|Sinfoo Biotech|SLING Consortium|Smolecule|Springer Nature|SpringerMaterials|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Syntree|TCI (Tokyo Chemical Industry)|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|TimTec|Tox21|ToxPlanet|Tractus|Vitas-M Laboratory|VladaChem|Wikidata|Wiley|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,""
15606394,Afatinib Dimaleate,"AFATINIB DIMALEATE|850140-73-7|Afatinib (diMaleate)|Gilotrif|Giotrif|Afatinib maleate|UNII-V1T5K7RZ0B|Afatinib dimaleate [USAN]|V1T5K7RZ0B|BIBW 2992MA2|BIBW2992 MA2|BIBW2992-MA2|BIBW-2992 MA2|CHEBI:76003|Afatinib (BIBW2992) Dimaleate|Afatinib maleate (JAN)|BIBW-2992MA2|(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide dimaleate|BIBW-2992-MA2|850140-73-7 (dimaleate)|Afatinib dimaleate (USAN)|(Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|AFATINIB MALEATE [JAN]|(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)|2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2e)-, (2Z)-2-butenedioate (1:2)|Gilotrif (TN)|(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((3S)-tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide di((2Z)-but-2-enedioate)|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate (1:2) (9CI); Afatinib dimaleate; BIBW 2992MA2|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide di[(2Z)-but-2-enedioate]|Afatinib Impurity F|Giotrif (TN)|EX-A065B|AFATINIB DIMALEATE [MI]|CHEMBL2105712|USNRYVNRPYXCSP-JUGPPOIOSA-N|AFATINIB DIMALEATE [VANDF]|DTXSID701027713|AFATINIB DIMALEATE [WHO-DD]|HY-10261A|s7810|AKOS025401819|CCG-270401|CS-1329|AFATINIB DIMALEATE [ORANGE BOOK]|BIBW2992-MA2 (Afatinib dimaleate)?|AC-26080|AS-56967|BA162012|D09733|Q27145677|(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)|(E)-4-Dimethylamino-But-2-Enoic Acid-(4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetra-Hydrofuran-3-Yloxy)-Quinazolin-6Yl)-Amide Dimaleate|1644565-87-6|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2)|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-,(2E)-, (2Z)-2-Butenedioate (1:2)",718.100,C32H33ClFN5O11,238.000,820.000,"",50,6,16,12,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",CN(C/C=C/C(=O)NC1=C(C=C2N=CN=C(C2=C1)NC3=CC(=C(C=C3)F)Cl)O[C@@H]4COCC4)C.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O,USNRYVNRPYXCSP-JUGPPOIOSA-N,(Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,717.1849127,717.1849127,0,3,0,1,1,0,3,3,0,1097,3789,921,Afatinib,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Associated Disorders and Diseases|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1250265|1250266|1250281|1250282|1250292|1250293|1409598|1640020|1645758|1694832|1694833|1694836|1694837|1694838|1694839|1694840|1694841|1694842|1694843|1694844|1694845|1694846|1694847|1835836|1836255|1836765|1837184|1837694|1838113|1838623|1839042|1839552|1839971|1840481|1840900|1841410|1841829|1842339|1842758|1843268|1843687|1844197|1844616|1912865|1912866|1912867|1913054|1913055|1913374|1913375|1913376|1915452|1915453|1915454|1915455|1915456|1915457|1915458|1915459|1915460|1915461|1915462|1915463|1915464|1915465|1915466|1915467|1915468|1915469|1915470|1915471|1915472|1915473|1915474|1915475|1915476|1915477|1915478|1915479|1962016,20070212,"A2B Chem|A2Z Chemical|AbaChemScene|AbovChem LLC|Achemtek|Acmec Biochemical|Acorn PharmaTech Product List|Activate Scientific|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AOBIOUS INC|ApexBio Technology|Apexmol|AstaTech, Inc.|AvaChem Scientific|BenchChem|Bic Biotech|BioCrick|Biosynth|BLD Pharm|BOC Sciences|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|CymitQuimica|DC Chemicals|DiscoveryGate|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|InvivoChem|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|Mcule|MedChemexpress MCE|MolGenie|Molport|MuseChem|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|SynHet - Synthetic Heterocycles|TargetMol|THE BioTek|Thomson Pharma|Tocris Bioscience|ToxPlanet|Uchem Meditech|VladaChem|Wikidata|Win-Win Chemical|Yuhao Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
10163178,Afatinib Impurity C,"Afatinib Impurity C|945553-91-3|(R)-Afatinib|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3R)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|439081-17-1|(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|CHEMBL2347958|R-afatinib|(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide; ent-Afatinib|Afatinib, (R)-|4L4QT28LW3|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3R)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|BDBM50406868|HY-10261E|AKOS030530514|AS-16246|DA-69192|FA103643|CS-0164261|F19226|A1-03523|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(R,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide? (Afatinib Impurity pound(c)|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide",485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m1/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@@H]4CCOC4,ULXXDDBFHOBEHA-QDLOVBKTSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3R)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.1629955,485.1629955,0,1,0,1,1,0,1,1,0,4,2,2,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,7,739423|739424|1359917|1359919|1359920|1359921|1359922|1359923|1359924|1359925|1359926|1359927|1424366|1424369|1424370|1424371|1424372|1424375|1959131|1959132|1959133|1959134|1959136,20061025,"001Chemical|10X CHEM|A1 BioChem Labs|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Accel Scientific|Adooq BioScience|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AppChem|AstaTech, Inc.|AvaChem Scientific|BenchChem|BindingDB|Biosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|InvivoChem|Key Organics/BIONET|Lan Pharmatech|LGC Standards|Mcule|MedChemexpress MCE|MolGenie|Molport|NextBio|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|TargetMol|THE BioTek|Thomson Pharma|Wutech|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
22225683,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide|Afatinib Impurity|1427463-78-2|N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide|Afatinib?|Afatinib (BIBW2992)?|SCHEMBL231073|SCHEMBL2269415|CHEMBL4102656|CHEBI:91400|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-(oxolan-3-yloxy)quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|AKOS032947299|NCGC00387813-02|NCGC00387813-03|EN300-19625331|BRD-A58767537-001-01-2|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,ULXXDDBFHOBEHA-ONEGZZNKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.1629955,485.1629955,0,1,0,1,0,1,1,1,0,5,13229,2588,"",Biological Test Results|Classification|Literature|Patents|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,7,1296008|1296009|1345084|1345085|1346986|1346987|1347055|1347159|1347160|1479145|1479147|1479149|1479150|1481311|1481348|1481349|1508620|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645874|1645876|1645877|1645878|1671188|1671193|1745853|1845192|1845220|1845221|1845222|1845223|1963596,20071205,"10X CHEM|3WAY PHARM INC|4C Pharma Scientific Inc|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|BenchChem|BioChemPartner|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|ChEBI|Chem-Space.com Database|ChEMBL|ChemSpider|DC Chemicals|eMolecules|Enamine|Ennopharm|EvitaChem|GlyTouCan Project|Google Patents|Hefei Hirisun Pharmatech Co., Ltd|Human Metabolome Database (HMDB)|Mcule|MolGenie|Molport|National Center for Advancing Translational Sciences (NCATS)|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|SCRIPDB|Smolecule|Starshine Chemical|SureChEMBL|University of Kansas High Throughput Screening Laboratory",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development,""
66555110,Afatinib impurity 11,Afatinib impurity 11|1402086-20-7|CHEMBL3622629|N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]prop-2-enamide|(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)acrylamide|BDBM50123214|AKOS040754626|DA-60828|MS-27602|HY-133780|CS-0131960|G18075,428.800,C21H18ClFN4O3,85.400,615.000,3.900,30,2,7,6,"InChI=1S/C21H18ClFN4O3/c1-2-20(28)27-18-8-14-17(9-19(18)30-13-5-6-29-10-13)24-11-25-21(14)26-12-3-4-16(23)15(22)7-12/h2-4,7-9,11,13H,1,5-6,10H2,(H,27,28)(H,24,25,26)/t13-/m0/s1",C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,MLHDLQIHGCIPJQ-ZDUSSCGKSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]prop-2-enamide,428.1051463,428.1051463,0,1,0,1,1,0,0,0,0,2,3,2,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,1250263,20121105,"10X CHEM|A2B Chem|AbaChemScene|Accel Scientific|AKos Consulting & Solutions|Amadis Chemical|AstaTech, Inc.|BindingDB|BOC Sciences|ChEMBL|DC Chemicals|Debye Scientific Co., Ltd|eNovation Chemicals|EvitaChem|Google Patents|InvivoChem|Key Organics/BIONET|Mcule|MedChemexpress MCE|MolGenie|Molport|Nature Chemical Biology|PATENTSCOPE (WIPO)|Probes & Drugs portal|Springer Nature|SynHet - Synthetic Heterocycles|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
53445376,Afatinib Impurity,Afatinib Impurity|(2Z)-Afatinib|MFCD12407405|Afatinib Impurity 3|CHEMBL2132902|(E/Z)-BIBW 2992|HMS3244L04|HMS3244L08|HMS3244L12|HMS3295G11|HMS3651A03|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3R)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|FSC18459|N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-(oxolan-3-yloxy)quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|MFCD31630115|AKOS026750415|PB28439|SY028094|SY047316|DS-015749|NS00040695|Q27163258|(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydrofuran-3-yl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(S)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[(3-tetrahydrofuranyl)oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|N-[4-(3-chloro-4-fluoroanilino)-7-(3-oxolanyloxy)-6-quinazolinyl]-4-(dimethylamino)-2-butenamide,485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)",CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,ULXXDDBFHOBEHA-UHFFFAOYSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.1629955,485.1629955,0,1,0,1,0,1,1,0,1,43,326,177,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active,5,624392|1347080|1508586|1508601|1918969,20111030,"A2B Chem|Acadechem|Accela ChemBio Inc.|AKos Consulting & Solutions|AlchemyPharm|Amfluoro|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Biocore|Biosynth|Cangzhou Enke Pharma Tech Co.,Ltd.|CAPOT|Chem-Impex|Chem-Space.com Database|ChEMBL|ChemieTek|Clearsynth|Cooke Chemical Co., Ltd|Debye Scientific Co., Ltd|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|Google Patents|Hairui Chemical|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MolCore|Molecule Market|MolGenie|MuseChem|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Starshine Chemical|Synblock Inc|Wikidata|Wubei-Biochem",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
15606392,"(S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine","314771-76-1|(S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine|(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine|Afatinib metabolite M20|Q58L53U44Y|4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine|MFCD18642925|Afatinib-des(4-dimethylamino-2-en-1-oxo)butyl (Contained ~8.5% Ethanol)|C18H16ClFN4O2|4,6-Quinazolinediamine, N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-|4,6-Quinazolinediamine, N4-(3-chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-|N4-(3-Chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine; (S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine; Des(4-dimethylamino-2-en-1-oxo)butyl Afatinib|UNII-Q58L53U44Y|SCHEMBL1190515|DTXSID10575638|6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydro-3-furanyl]oxy]quinazoline|BIQABKFYKJRXII-NSHDSACASA-N|N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine|CS-M0993|AKOS016000567|DS-5451|AC-26216|DB-336386|NS00077952|Q27287020|(S)-N-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine|4-[(3-Chloro-4-fluorophenyl)amino]-6-amino-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline|N~4~-(3-Chloro-4-fluorophenyl)-7-{[(3S)-oxolan-3-yl]oxy}quinazoline-4,6-diamine|N4-(3-chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine, (S)-",374.800,C18H16ClFN4O2,82.300,476.000,3.500,26,2,7,4,"InChI=1S/C18H16ClFN4O2/c19-13-5-10(1-2-14(13)20)24-18-12-6-15(21)17(7-16(12)22-9-23-18)26-11-3-4-25-8-11/h1-2,5-7,9,11H,3-4,8,21H2,(H,22,23,24)/t11-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N,BIQABKFYKJRXII-NSHDSACASA-N,"4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine",374.0945816,374.0945816,0,1,0,1,1,0,0,0,0,2,161,41,"",Classification|Literature|Patents|Safety and Hazards,4,"",20070212,"001Chemical|10X CHEM|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Accel Scientific|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Apexmol|AppChem|Arromax Pharmatech Co., Ltd|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|Bic Biotech|BLD Pharm|BOC Sciences|Cangzhou Enke Pharma Tech Co.,Ltd.|CEGChem|Chem-Space.com Database|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Combi-Blocks|CymitQuimica|Day Biochem|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|Elsa Biotechnology|eMolecules|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Founder Pharma|Google Patents|Hangzhou APIChem Technology|IBM|iChemical Technology USA Inc|J&H Chemical Co.,ltd|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|Matrix Scientific|Mcule|Molepedia|MolGenie|Molport|MuseChem|Nature Chemical Biology|NextBio|NextMove Software|NORMAN Suspect List Exchange|Oakwood Products|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Race Chemical|RR Scientific|SCRIPDB|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Synthonix, Inc.|Syntree|Tenova Pharmaceuticals Inc|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|Wikidata|Win-Win Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
70855894,"(2R-(1(S),2alpha,4beta))-1-(2-(((1,1-Dimethylethoxy)carbonyl)amino)-5-((imino(nitroamino)methyl)amino)-1-oxopentyl)-4-methyl-2-piperidinecarboxylic acid ethyl ester","74874-07-0|[2R-[1(S),2alpha,4beta]]-1-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid ethyl ester|(2R-(1(S),2alpha,4beta))-1-(2-(((1,1-Dimethylethoxy)carbonyl)amino)-5-((imino(nitroamino)methyl)amino)-1-oxopentyl)-4-methyl-2-piperidinecarboxylic acid ethyl ester|3R5KS98YUK|SCHEMBL16774894|CS-0164175|(2R,4R)-1-[(2S)-2-[[(1,1- Dimethylethoxy)carbonyl]amino]-5-[[imino(nitroamino)methyl]amino]-1- oxopentyl]-4-methyl-2-piperidinecarboxylic Acid Ethyl Ester (Afatinib Impurity pound(c)|2-Piperidinecarboxylic acid, 1-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-, ethyl ester, (2R,4R)-|2-Piperidinecarboxylic acid, 1-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-, ethyl ester, [2R-[1(S*),2alpha,4beta]]-|806-441-2|Ethyl (2R,4R)-1-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylate",472.500,C20H36N6O7,181.000,731.000,1.800,33,3,8,12,"InChI=1S/C20H36N6O7/c1-6-32-17(28)15-12-13(2)9-11-25(15)16(27)14(23-19(29)33-20(3,4)5)8-7-10-22-18(21)24-26(30)31/h13-15H,6-12H2,1-5H3,(H,23,29)(H3,21,22,24)/t13-,14+,15-/m1/s1",CCOC(=O)[C@H]1C[C@@H](CCN1C(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])NC(=O)OC(C)(C)C)C,IXUJSLMIDVNADJ-QLFBSQMISA-N,"ethyl (2R,4R)-1-[(2S)-5-[[amino(nitramido)methylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]-4-methylpiperidine-2-carboxylate",472.26454751,472.26454751,0,1,0,3,3,0,0,0,0,1,7,2,"",Classification|Literature|Patents|Safety and Hazards,4,"",20130321,"AbaChemScene|Chemieliva Pharmaceutical Co., Ltd|FDA Global Substance Registration System (GSRS)|Google Patents|iChemical Technology USA Inc|J&H Chemical Co.,ltd|MolGenie|PubChem Reference Collection|SureChEMBL|Thieme Chemistry|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
9898830,Ethyl 2-(oxiran-2-yl)acetate,"Ethyl oxiraneacetate|32223-97-5|Ethyl 2-(oxiran-2-yl)acetate|ethyl 3,4-epoxybutyrate|ethyl 3,4-epoxybutanoate|oxiraneacetic acid ethyl ester|Oxiraneacetic acid, ethyl ester|SCHEMBL3062283|WHUSTVAXKRFVPD-UHFFFAOYSA-N|HBA22397|AS-84365|DB-060159|CS-0164315|E77752|EN300-1663173|Z1255420015|ethyl 2-(oxiran-2-yl)acetate? (Afatinib Impurity pound(c)|847-258-8",130.139,C6H10O3,38.800,111.000,0.100,9,0,3,4,"InChI=1S/C6H10O3/c1-2-8-6(7)3-5-4-9-5/h5H,2-4H2,1H3",CCOC(=O)CC1CO1,WHUSTVAXKRFVPD-UHFFFAOYSA-N,ethyl 2-(oxiran-2-yl)acetate,130.062994177,130.062994177,0,1,0,1,0,1,0,0,0,5,68,23,"",Classification|Literature|Patents|Safety and Hazards,4,"",20061025,"10X CHEM|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Accel Scientific|Achemica|Ambinter|AppChem|Aribo Reagent|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|Biocore|Biosynth|CAPOT|Chemenu Inc.|ChemSpider|ChemTik|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|Enamine|eNovation Chemicals|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|Innovapharm|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|Mcule|MolCore|MolGenie|Molport|NextBio|NextMove Software|PATENTSCOPE (WIPO)|PubChem Reference Collection|RR Scientific|SCRIPDB|Sinfoo Biotech|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Thieme Chemistry|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
131954672,BIBW2992-MA2 (Afatinib dimaleate),850140-73-7|BIBW2992-MA2 (Afatinib dimaleate),718.100,C32H33ClFN5O11,238.000,820.000,"",50,6,16,12,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;;/t16-;;/m0../s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,USNRYVNRPYXCSP-IACUOYJGSA-N,but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,717.1849127,717.1849127,0,3,0,1,1,0,3,1,2,0,0,0,"",Classification|Drug and Medication Information|Safety and Hazards,3,"",20180117,Accel Scientific|Starshine Chemical,Chemical Vendors,""
117821692,"(S,E)-4-broMo-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enaMide","Afatinib Impurity I|1637254-93-3|Bromo-Afatinib|(S,E)-4-broMo-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enaMide|(E)-4-bromo-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide|(2E)-4-Bromo-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide|AFATINIB IMPURITY O|2-Butenamide, 4-bromo-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-, (2E)- (ACI); (2E)-4-Bromo-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide (ACI)|C22H19BrClFN4O3|5WWC96C6TZ|SCHEMBL16398947|SCHEMBL16398952|IQJWAIKYBNTYPG-YUKKFKLSSA-N|CS-0164267|(S,E)-4-Bromo-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity)|2-Butenamide, 4-bromo-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-, (2E)-|4-Bromo-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide, (2E)-",521.799,C22H19BrClFN4O3,85.400,663.000,4.400,32,2,7,7,"InChI=1S/C22H19BrClFN4O3/c23-6-1-2-21(30)29-19-9-15-18(10-20(19)32-14-5-7-31-11-14)26-12-27-22(15)28-13-3-4-17(25)16(24)8-13/h1-4,8-10,12,14H,5-7,11H2,(H,29,30)(H,26,27,28)/b2-1+/t14-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC(=O)/C=C/CBr,IQJWAIKYBNTYPG-YUKKFKLSSA-N,(E)-4-bromo-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide,520.03131,520.03131,0,1,0,1,1,0,1,1,0,1,14,4,"",Classification|Literature|Patents,3,"",20160223,"001Chemical|10X CHEM|A2B Chem|AbaChemScene|Acmec Biochemical|Amadis Chemical|AppChem|AstaTech, Inc.|BenchChem|Bic Biotech|BLD Pharm|BOC Sciences|CymitQuimica|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|LGC Standards|Mcule|Molport|NextMove Software|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|THE BioTek|Thieme Chemistry|Thoreauchem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
15606393,Diethyl P-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)amino)-2-oxoethyl)phosphonate,"618061-76-0|(S)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate|CID 15606393|Diethyl (S)-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate|PHOSPHONIC ACID,[2-[[4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-7-[[(3S)-TETRAHYDRO-3-FURANYL]OXY]-6-QUINAZOLINYL]AMINO]-2-OXOETHYL]-, DIETHYL ESTER|N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-diethoxyphosphorylacetamide|Diethyl (S)-2-Amino-2-oxoethyl Phosphonate Afatinib|(S)-Diethyl (2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate|Diethyl P-[2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]phosphonate|Diethyl P-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)amino)-2-oxoethyl)phosphonate|MFCD19440885|C24H27ClFN4O6P|D8XUT95J9B|SCHEMBL436188|DTXSID70575639|FNGRCLBEXKFSST-INIZCTEOSA-N|AKOS025405463|AS-75229|diethyl [({4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}carbamoyl)methyl]phosphonate|Diethyl {[4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetrahydrofuran-3-Yloxy)-Quinazolin-6-Ylcarbamoyl]-Methyl}-Phosphonate|DB-189978|CS-0008486|NS00077605|C75900|(S)-diethyl2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate|diethyl ({4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}carbamoyl)methylphosphonate|Diethyl (2-{[4-(3-chloro-4-fluoroanilino)-7-{[(3S)-oxolan-3-yl]oxy}quinazolin-6-yl]amino}-2-oxoethyl)phosphonate|Diethyl (S)-2-Amino-2-oxoethyl Phosphonate Afatinib; Phosphonic acid, P-[2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]-, diethyl ester (ACI); Diethyl P-[2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amin|Phosphonic acid, [2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]-, diethyl ester|Phosphonic acid, P-[2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]-, diethyl ester",552.900,C24H27ClFN4O6P,121.000,792.000,3.900,37,2,10,11,"InChI=1S/C24H27ClFN4O6P/c1-3-34-37(32,35-4-2)13-23(31)30-21-10-17-20(11-22(21)36-16-7-8-33-12-16)27-14-28-24(17)29-15-5-6-19(26)18(25)9-15/h5-6,9-11,14,16H,3-4,7-8,12-13H2,1-2H3,(H,30,31)(H,27,28,29)/t16-/m0/s1",CCOP(=O)(CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)OCC,FNGRCLBEXKFSST-INIZCTEOSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-diethoxyphosphorylacetamide,552.1340774,552.1340774,0,1,0,1,1,0,0,0,0,1,66,8,"",Classification|Literature|Patents,3,"",20070212,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Accel Scientific|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Angene Chemical|Apexmol|AppChem|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|CEGChem|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Combi-Blocks|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|J&H Chemical Co.,ltd|Key Organics/BIONET|King Scientific|Lan Pharmatech|LGC Standards|Matrix Scientific|Mcule|Molecule Market|MolGenie|Molport|NextBio|NextMove Software|NORMAN Suspect List Exchange|Paragos|PATENTSCOPE (WIPO)|PubChem Reference Collection|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Synthonix, Inc.|Tenova Pharmaceuticals Inc|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|Wikidata|Wolves R&D chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
57514094,N-Nitro tetradehydroargatroban,"74874-10-5|Argatroban-6|(2R,4R)-1-[(2S)-5-[[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SULFONYL]AMINO]-1-OXOPENTYL]-4-METHYL-2-PIPERIDINECARBOXYLIC ACID|N-Nitro-1,2,3,4-tetradehydro Argatroban|86JF2UKF4B|N-Nitro tetradehydroargatroban|UNII-86JF2UKF4B|N-Nitro tetradehydroargatroban [USP]|(2R,4R)-1-[(2S)-5-[[amino(nitramido)methylidene]amino]-2-[(3-methylquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid|N-NITRO TETRADEHYDROARGATROBAN [USP IMPURITY]|N-Nitro tetradehydroargatroban (USP)|(2R,4R)-1-(N8-Nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl)-4-methylpiperidine-2-carboxylic acid|(2R,4R)-4-Methyl-1-((S)-2-(3-methylquinoline-8-sulfonamido)-5-(3-nitroguanidino)pentanoyl)piperidine-2-carboxylic acid|1-(N8-Nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl)-4-methylpiperidine-2-carboxylic acid, (2R,4R)-|N-NITRO TETRADEHYDROARGATROBAN (USP IMPURITY)|AKOS016010211|2-Piperidinecarboxylic acid, 1-[(2S)-5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, (2R,4R)-|CS-0164168|(2R,4R)-1-(N8-NITRO-N2-(3-METHYLQUINOLINE-8-SULFONYL)-L-ARGINYL)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID|(2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2- [[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity|(2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2- [[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)|(2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylicAcid(AfatinibImpurity pound(c)|1-(N8-NITRO-N2-(3-METHYLQUINOLINE-8-SULFONYL)-L-ARGINYL)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID, (2R,4R)-|2-Piperidinecarboxylic acid, 1-[5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-, [2R-[1(S*),2alpha,4beta]]-|74872-83-6",549.600,C23H31N7O7S,221.000,997.000,1.700,38,4,10,10,"InChI=1S/C23H31N7O7S/c1-14-8-10-29(18(12-14)22(32)33)21(31)17(6-4-9-25-23(24)27-30(34)35)28-38(36,37)19-7-3-5-16-11-15(2)13-26-20(16)19/h3,5,7,11,13-14,17-18,28H,4,6,8-10,12H2,1-2H3,(H,32,33)(H3,24,25,27)/t14-,17+,18-/m1/s1",C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])NS(=O)(=O)C2=CC=CC3=C2N=CC(=C3)C,XBDLKMBSCAVLDV-FHLIZLRMSA-N,"(2R,4R)-1-[(2S)-5-[[amino(nitramido)methylidene]amino]-2-[(3-methylquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",549.20056753,549.20056753,0,1,0,3,3,0,0,0,0,1,2,1,"",Classification|Literature|Patents,3,"",20120808,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|Acmec Biochemical|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Angene Chemical|Apexmol|AppChem|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|Bic Biotech|BLD Pharm|BOC Sciences|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|CymitQuimica|eMolecules|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|IBM|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LGC Standards|Matrix Scientific|Mcule|Molepedia|Molport|MuseChem|OXCHEM CORPORATION|PubChem Reference Collection|Race Chemical|RR Scientific|Smolecule|Starshine Chemical|SynHet - Synthetic Heterocycles|THE BioTek|Thieme Chemistry|Thomson Pharma|Win-Win Chemical|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
59868521,2-Amino-4-fluoro-5-nitrobenzoic acid,2-amino-4-fluoro-5-nitrobenzoic acid|1194097-41-0|SCHEMBL13999989|UXB09741|2-amino-4-fluoro-5-nitrobenzoicacid|CS-0164291|EN300-65911|E73753|2-amino-4-fluoro-5-nitrobenzoic acid? (Afatinib Impurity pound(c)|963-337-0,200.120,C7H5FN2O4,109.000,255.000,1.200,14,2,6,1,"InChI=1S/C7H5FN2O4/c8-4-2-5(9)3(7(11)12)1-6(4)10(13)14/h1-2H,9H2,(H,11,12)",C1=C(C(=CC(=C1[N+](=O)[O-])F)N)C(=O)O,NVZBXVCRFGPOAJ-UHFFFAOYSA-N,2-amino-4-fluoro-5-nitrobenzoic acid,200.02333481,200.02333481,0,1,0,0,0,0,0,0,0,0,6,2,"",Classification|Patents|Safety and Hazards,3,"",20120820,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|AHH Chemical co.,ltd|Amadis Chemical|Ambeed|Ambinter|Amfluoro|AppChem|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|Biosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|CymitQuimica|eMolecules|Enamine|eNovation Chemicals|Google Patents|Hairui Chemical|IBM|LGC Standards|Mcule|MolGenie|Molport|PATENTSCOPE (WIPO)|PubChem Reference Collection|SCRIPDB|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|THE BioTek|Wutech|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
21847811,N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine,"N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine|179552-74-0|Afatinib Impurity 5|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitro-|MFCD27975589|C15H10ClFN4O3|SCHEMBL26162|97MR5WE3S3|VKEKKVCWODTGAP-UHFFFAOYSA-N|AKOS027447381|DS-19074|DB-125444|CS-0150557|C73412|4-(3-chloro-4-fluorophenylamino)-6-nitro-7-methoxyquinazoline|N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitro-4-quinazolinamine|(3-Chloro-4-fluoro-phenyl)-(7-methoxy-6-nitro-quinazolin-4-yl)-amine",348.710,C15H10ClFN4O3,92.900,455.000,3.900,24,1,7,3,"InChI=1S/C15H10ClFN4O3/c1-24-14-6-12-9(5-13(14)21(22)23)15(19-7-18-12)20-8-2-3-11(17)10(16)4-8/h2-7H,1H3,(H,18,19,20)",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)[N+](=O)[O-],VKEKKVCWODTGAP-UHFFFAOYSA-N,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine,348.0425460,348.0425460,0,1,0,0,0,0,0,0,0,1,133,27,"",Classification|Literature|Patents,3,"",20071205,"001Chemical|10X CHEM|1st Scientific|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Accel Scientific|Acmec Biochemical|Acorn PharmaTech Product List|Activate Scientific|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alichem|Amadis Chemical|Ambeed|Ambinter|Amfluoro|Angel Pharmatech Ltd.|Apexmol|AppChem|Ark Pharm, Inc.|AstaTech, Inc.|BenchChem|BePharm Ltd.|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Clearsynth|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LEAPCHEM|LGC Standards|Mcule|MolCore|Molecule Market|Molport|MuseChem|Nature Chemical Biology|NextMove Software|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|RR Scientific|SCRIPDB|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Synthonix, Inc.|TargetMol|Thomson Pharma|Thoreauchem|Win-Win Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
15697773,"Ethyl (2S,4S)-4-Methylpipecolate","78306-52-2|Ethyl (2S,4S)-4-methylpiperidine-2-carboxylate|(2S,4S)-Ethyl 4-methylpiperidine-2-carboxylate|Ethyl (2S,4S)-4-Methylpipecolate|74863-85-7|(2S,4S)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester; (2S-trans)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester;|starbld0000503|SCHEMBL8578784|GHBNOCBWSUHAAA-YUMQZZPRSA-N|MFCD27928752|PS-19577|DB-254641|CS-0163985|F78213|EN300-6221122|rac-ethyl (2R,4R)-4-methylpiperidine-2-carboxylate|(2S-trans)-4-Methyl-2-piperidinecarboxylic acid, ethyl ester|Ethyl (2S,4S)-4-methylpiperidine-2-carboxylate (Afatinib Impurity pound(c)",171.240,C9H17NO2,38.300,159.000,1.400,12,1,3,3,"InChI=1S/C9H17NO2/c1-3-12-9(11)8-6-7(2)4-5-10-8/h7-8,10H,3-6H2,1-2H3/t7-,8-/m0/s1",CCOC(=O)[C@@H]1C[C@H](CCN1)C,GHBNOCBWSUHAAA-YUMQZZPRSA-N,"ethyl (2S,4S)-4-methylpiperidine-2-carboxylate",171.125928785,171.125928785,0,1,0,2,2,0,0,0,0,1,31,6,"",Literature|Patents|Spectral Information,3,"",20070212,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Achemo Scientific Limited|Activate Scientific|AiFChem, an XtalPi Company|Amadis Chemical|Ambinter|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|CymitQuimica|Debye Scientific Co., Ltd|eMolecules|Enamine|eNovation Chemicals|Google Patents|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LGC Standards|Mcule|Molecule Market|Molport|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Thieme Chemistry|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
97041548,(2Z)-Afatinib,"1680184-59-1|(2Z)-Afatinib|(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|Afatinib Impurity D (Z-Afatinib)|(S,Z)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|Afatinib Impurity|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2Z)-|Afatinib, (2Z)-|8VCD8UD2U3|DTXSID501103129|AKOS025401063|CS-0164262|(2Z)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(S,Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide;Z-Afatinib? (Afatinib Impurity pound(c)|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3R)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2Z)-",485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3-/t16-/m0/s1",CN(C)C/C=C\C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,ULXXDDBFHOBEHA-QGZUEGPWSA-N,(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.1629955,485.1629955,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification|Patents,2,"",20151211,"AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Amadis Chemical|BenchChem|BLD Pharm|BOC Sciences|Clearsynth|CymitQuimica|DAOGE BIOPHARMA|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|LabNetwork, a WuXi AppTec Company|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
130345348,Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib,2223677-58-3|1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(((S)-TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-5-HYDROXYPYRROLIDIN-2-ONE|1-(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Afatinib Impurity)|Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib|SCHEMBL19260126|1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-5-hydroxypyrrolidin-2-one|1-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-5-hydroxy-2-pyrrolidinone|CS-0164322|E82042|1-(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-5-hydroxypyrrolidin-2-one? (Afatinib Impurity pound(c)|Afatinib impurity 11/Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib,458.900,C22H20ClFN4O4,96.800,678.000,3.100,32,2,8,5,"InChI=1S/C22H20ClFN4O4/c23-15-7-12(1-2-16(15)24)27-22-14-8-18(28-20(29)3-4-21(28)30)19(9-17(14)25-11-26-22)32-13-5-6-31-10-13/h1-2,7-9,11,13,20,29H,3-6,10H2,(H,25,26,27)/t13-,20?/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N5C(CCC5=O)O,HIMWAPFLBWDJMH-SZQRVLIRSA-N,1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-5-hydroxypyrrolidin-2-one,458.1157110,458.1157110,0,1,0,2,1,1,0,0,0,0,4,2,"",Classification|Patents,2,"",20171007,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|Acmec Biochemical|Amadis Chemical|AstaTech, Inc.|BLD Pharm|BOC Sciences|CymitQuimica|EvitaChem|Google Patents|LGC Standards|Mcule|Molport|SureChEMBL|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Research and Development,""
154631180,"(S,E)-N-(4-((4-Chloro-3-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)","2475094-87-0|(S,E)-N-(4-((4-Chloro-3-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)|(S,E)-N-(4-((4-CHLORO-3-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE|2-Butenamide, N-[4-[(4-chloro-3-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-|3-Dechloro-4-defluoro 4-Chloro-3-fluoro Afatinib|4-Chloro-3-fluoro Afatinib|Afatinib Impurity G|G6YTK9H6LE|CS-0164265|E82035|(2E)-N-[4-[(4-Chloro-3-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(E)-N-[4-(4-chloro-3-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|(S,E)-N-(4-((4-Chloro-3-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide? (Afatinib Impurity pound(c)|2-Butenamide, N-[4-[(4-chloro-3-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-|N-[4-[(4-Chloro-3-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide",485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-18(25)19(26)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)F)O[C@H]4CCOC4,CIGJZGGVLAOLAG-CWDCEQMOSA-N,(E)-N-[4-(4-chloro-3-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.1629955,485.1629955,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification|Patents,2,"",20200928,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|Acmec Biochemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|LGC Standards|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
154631189,"(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)","2223677-62-9|(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)|3-Fluoro-Afatinib|(S,E)-N-(4-((3,4-DIFLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE|(2E)-N-[4-[(3,4-Difluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|Afatinib IMpurity SF|Y9FZ6Q3GLL|(E)-N-[4-(3,4-difluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|CS-0164264|E82034|2-Butenamide, N-[4-[(3,4-difluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-|3-Fluoro-Afatinib; 2-Butenamide, N-[4-[(3,4-difluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)- (ACI); (2E)-N-[4-[(3,4-Difluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (ACI|N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, (S,E)-",469.500,C24H25F2N5O3,88.600,700.000,3.100,34,2,9,8,"InChI=1S/C24H25F2N5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-18(25)19(26)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)F)O[C@H]4CCOC4,HGIMFDMPTIPMFG-CWDCEQMOSA-N,"(E)-N-[4-(3,4-difluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide",469.19254600,469.19254600,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification|Patents,2,"",20200928,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|Acmec Biochemical|Amadis Chemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|CymitQuimica|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|LGC Standards|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
92135819,N-desmethyl afatinib,"N-desmethyl afatinib|2413212-13-0|(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(methylamino)but-2-enamide (Afatinib Impurity)|(S,E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(METHYLAMINO)BUT-2-ENAMIDE|AFATINIB METABOLITE M10|43KI824L19|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(methylamino)-, (2E)-|CS-0164269|E82038|Q27258653|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(methylamino)but-2-enamide",471.900,C23H23ClFN5O3,97.400,674.000,3.200,33,3,8,8,"InChI=1S/C23H23ClFN5O3/c1-26-7-2-3-22(31)30-20-10-16-19(11-21(20)33-15-6-8-32-12-15)27-13-28-23(16)29-14-4-5-18(25)17(24)9-14/h2-5,9-11,13,15,26H,6-8,12H2,1H3,(H,30,31)(H,27,28,29)/b3-2+/t15-/m0/s1",CNC/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,XMAATFWFFWESFY-FAAWYNLUSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(methylamino)but-2-enamide,471.1473455,471.1473455,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification|Patents,2,"",20151204,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Accel Scientific|Acmec Biochemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations,""
125342095,"(S)-N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine (Afatinib Impurity)","2413212-07-2|(S)-N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine (Afatinib Impurity)|(S)-N4-(4-FLUOROPHENYL)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLINE-4,6-DIAMINE|Deschloro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib|Afatinib Impurity 6|SBW3JMP6HJ|CS-0255330|F83293|4,6-Quinazolinediamine, N4-(4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-|N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine, (S)-|N4-(4-Fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine",340.400,C18H17FN4O2,82.300,435.000,2.900,25,2,7,4,"InChI=1S/C18H17FN4O2/c19-11-1-3-12(4-2-11)23-18-14-7-15(20)17(8-16(14)21-10-22-18)25-13-5-6-24-9-13/h1-4,7-8,10,13H,5-6,9,20H2,(H,21,22,23)/t13-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC=C(C=C4)F)N,DCBBEFYNODKZDK-ZDUSSCGKSA-N,"4-N-(4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine",340.13355396,340.13355396,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20170410,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|LGC Standards|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
76967686,afatinib N-oxide,"afatinib N-oxide|2413212-11-8|(S,E)-4-((4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-N,N-dimethyl-4-oxobut-2-en-1-amine oxide|(S)-4-((4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-N,N-dimethyl-4-oxobut-2-en-1-amine oxide|2577271-30-6|Afatinib Impurity N-Oxide|F3S5OLD39D|BJ475R2M7W|AFATINIB METABOLITE M15|AKOS040732394|HY-133110|CS-0111197|Q27277592|(2E)-N-(4-(3-CHLORO-4-FLUOROANILINO)-7-(((3S)-OXOLAN-3-YL)OXY)QUINOXAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE N-OXIDE|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyloxidoamino)-2-butenamide|(E)-4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-N,N-dimethyl-4-oxobut-2-en-1-amine oxide|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyloxidoamino)-, (2E)-",501.900,C24H25ClFN5O4,103.000,747.000,3.100,35,2,8,8,"InChI=1S/C24H25ClFN5O4/c1-31(2,33)8-3-4-23(32)30-21-11-17-20(12-22(21)35-16-7-9-34-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",C[N+](C)(C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)[O-],IABSYXLQTGEUIV-CWDCEQMOSA-N,"(E)-4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-N,N-dimethyl-4-oxobut-2-en-1-amine oxide",501.1579102,501.1579102,0,1,0,1,1,0,1,1,0,0,5,1,"",Classification|Patents,2,"",20140825,"AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|BLD Pharm|BOC Sciences|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|FDA Global Substance Registration System (GSRS)|Google Patents|InvivoChem|MedChemexpress MCE|PATENTSCOPE (WIPO)|TargetMol|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
127256267,"(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity)","2223677-64-1|(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity)|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide|(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide|Afatinib Impurity des-EJA|M56A58DLR9|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide|CS-0164266|E82036|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-, (2E)-|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide, (S,E)-",442.900,C22H20ClFN4O3,85.400,642.000,4.200,31,2,7,6,"InChI=1S/C22H20ClFN4O3/c1-2-3-21(29)28-19-9-15-18(10-20(19)31-14-6-7-30-11-14)25-12-26-22(15)27-13-4-5-17(24)16(23)8-13/h2-5,8-10,12,14H,6-7,11H2,1H3,(H,28,29)(H,25,26,27)/b3-2+/t14-/m0/s1",C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,IRSLBGKNPBBZSA-HSWBROFVSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide,442.1207964,442.1207964,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification|Patents,2,"",20170618,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|Amadis Chemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|Clearsynth|CymitQuimica|eMolecules|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
154631182,(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide (Afatinib Impurity),"2223677-60-7|(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide (Afatinib Impurity)|(S)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)FORMAMIDE|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]formamide|Afatinib Impurity JXH|KZQ2AK8THN|CS-0255327|F83292|Formamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide, (S)-",402.800,C19H16ClFN4O3,85.400,533.000,3.400,28,2,7,5,"InChI=1S/C19H16ClFN4O3/c20-14-5-11(1-2-15(14)21)25-19-13-6-17(24-10-26)18(7-16(13)22-9-23-19)28-12-3-4-27-8-12/h1-2,5-7,9-10,12H,3-4,8H2,(H,24,26)(H,22,23,25)/t12-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC=O,ZBGVNMZERFYSES-LBPRGKRZSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]formamide,402.0894962,402.0894962,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|Amadis Chemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
44542522,Afatinib Impurity 2F3Cl-1,"936558-43-9|Afatinib Impurity 2F3Cl-1|SCHEMBL4576452|U2YY78T426|4-Quinazolinamine, N-(3-chloro-2-fluorophenyl)-7-fluoro-6-nitro-|DB-417911|CS-0164297|N-(3-chloro-2-fluorophenyl)-7-fluoro-6-nitro-4-Quinazolinamine|N-(3-chloro-2-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine|N-(3-chloro-2-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine? (Afatinib Impurity pound(c)",336.680,C14H7ClF2N4O2,83.600,441.000,4.100,23,1,7,2,"InChI=1S/C14H7ClF2N4O2/c15-8-2-1-3-10(13(8)17)20-14-7-4-12(21(22)23)9(16)5-11(7)18-6-19-14/h1-6H,(H,18,19,20)",C1=CC(=C(C(=C1)Cl)F)NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F,IQAPIVVBQOMPON-UHFFFAOYSA-N,N-(3-chloro-2-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine,336.0225595,336.0225595,0,1,0,0,0,0,0,0,0,0,19,4,"",Classification|Patents,2,"",20100111,"AbaChemScene|BOC Sciences|Debye Scientific Co., Ltd|DiscoveryGate|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|PATENTSCOPE (WIPO)|SureChEMBL|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
154631205,"N3-(3-Dimethylamino,1-carboxyprop-2-yl) Afatinib","N3-(3-Dimethylamino,1-carboxyprop-2-yl) Afatinib",615.100,C30H36ClFN6O5,120.000,947.000,1.100,43,2,11,13,"InChI=1S/C30H36ClFN6O5/c1-36(2)10-5-6-28(39)35-26-14-22-25(15-27(26)43-21-9-11-42-17-21)33-18-34-30(22)38(19-7-8-24(32)23(31)12-19)20(13-29(40)41)16-37(3)4/h5-8,12,14-15,18,20-21H,9-11,13,16-17H2,1-4H3,(H,35,39)(H,40,41)/b6-5+/t20?,21-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)N(C3=CC(=C(C=C3)F)Cl)C(CC(=O)O)CN(C)C)O[C@H]4CCOC4,IQIVXRKRCBYOEI-BYQLTYQASA-N,3-(3-chloro-N-[6-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-yl]-4-fluoroanilino)-4-(dimethylamino)butanoic acid,614.2419741,614.2419741,0,1,0,2,1,1,1,1,0,0,0,0,"",Classification|Patents,2,"",20200928,LGC Standards|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
154631193,Afatinib Dimer,Afatinib Dimer,971.900,C48H50Cl2F2N10O6,168.000,1650.000,6.900,68,3,16,18,"InChI=1S/C48H50Cl2F2N10O6/c1-60(2)13-5-6-45(63)58-42-20-34-40(22-44(42)68-32-12-15-66-25-32)54-27-56-48(34)62(29-8-10-38(52)36(50)17-29)30(23-61(3)4)18-46(64)59-41-19-33-39(21-43(41)67-31-11-14-65-24-31)53-26-55-47(33)57-28-7-9-37(51)35(49)16-28/h5-10,16-17,19-22,26-27,30-32H,11-15,18,23-25H2,1-4H3,(H,58,63)(H,59,64)(H,53,55,57)/b6-5+/t30?,31-,32-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)N(C3=CC(=C(C=C3)F)Cl)C(CC(=O)NC4=C(C=C5C(=C4)C(=NC=N5)NC6=CC(=C(C=C6)F)Cl)O[C@H]7CCOC7)CN(C)C)O[C@H]8CCOC8,GRHQVOFTIOOKMN-BRTSVNRHSA-N,3-(3-chloro-N-[6-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-yl]-4-fluoroanilino)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)butanamide,970.3259911,970.3259911,0,1,0,3,2,1,1,1,0,0,0,0,"",Classification|Patents,2,"",20200928,LGC Standards|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
117679264,N-(3-Chloro-4-fluorophenyl)-7-ethoxy-6-nitroquinazolin-4-amine (Afatinib Impurity),"1360430-70-1|N-(3-Chloro-4-fluorophenyl)-7-ethoxy-6-nitroquinazolin-4-amine (Afatinib Impurity)|N-(3-chloro-4-fluorophenyl)-7-ethoxy-6-nitroquinazolin-4-amine|N-(3-Chloro-4-fluorophenyl)-7-ethoxy-6-nitro-4-quinazolinamine|CTM8G2J55A|SCHEMBL16212087|JMGHGGXIWOGJQO-UHFFFAOYSA-N|DB-091855|CS-0200325|F82978|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-ethoxy-6-nitro-",362.740,C16H12ClFN4O3,92.900,469.000,4.300,25,1,7,4,"InChI=1S/C16H12ClFN4O3/c1-2-25-15-7-13-10(6-14(15)22(23)24)16(20-8-19-13)21-9-3-4-12(18)11(17)5-9/h3-8H,2H2,1H3,(H,19,20,21)",CCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)[N+](=O)[O-],JMGHGGXIWOGJQO-UHFFFAOYSA-N,N-(3-chloro-4-fluorophenyl)-7-ethoxy-6-nitroquinazolin-4-amine,362.0581961,362.0581961,0,1,0,0,0,0,0,0,0,0,12,4,"",Classification|Patents,2,"",20160223,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|AppChem|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|Debye Scientific Co., Ltd|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|Mcule|Molport|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
154631208,Afatinib impurity 12,"Afatinib impurity 12|2121530-37-6|(2E)?-N-?[4-?[(3-?chloro-?4-?fluorophenyl)?amino]?-?7-?[[(3S)?-?tetrahydro-?3-?furanyl]?oxy]?-?6-?quinazolinyl]?-?4-?hydroxy-2-?butenamide|(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-hydroxybut-2-enamide",458.900,C22H20ClFN4O4,106.000,659.000,2.900,32,3,8,7,"InChI=1S/C22H20ClFN4O4/c23-16-8-13(3-4-17(16)24)27-22-15-9-19(28-21(30)2-1-6-29)20(10-18(15)25-12-26-22)32-14-5-7-31-11-14/h1-4,8-10,12,14,29H,5-7,11H2,(H,28,30)(H,25,26,27)/b2-1+/t14-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC(=O)/C=C/CO,XZMUSENASPIMAT-YUKKFKLSSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-hydroxybut-2-enamide,458.1157110,458.1157110,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification|Patents,2,"",20200928,"10X CHEM|A2B Chem|BLD Pharm|LGC Standards|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Governmental Organizations|Legacy Depositors,""
137285542,Afatinib Impurity 2,"1449430-45-8|4-((3-Chloro-4-fluorophenyl)amino)-6-nitroquinazolin-7-ol|4-[(3-chloro-4-fluorophenyl)amino]-6-nitroquinazolin-7-ol|Afatinib Impurity 2|7V6T6A4TES|SCHEMBL20305667|7-Quinazolinol, 4-[(3-chloro-4-fluorophenyl)amino]-6-nitro-|4-[(3-Chloro-4-fluorophenyl)amino]-6-nitro-7-quinazolinol",334.690,C14H8ClFN4O3,104.000,441.000,4.200,23,2,7,2,"InChI=1S/C14H8ClFN4O3/c15-9-3-7(1-2-10(9)16)19-14-8-4-12(20(22)23)13(21)5-11(8)17-6-18-14/h1-6,21H,(H,17,18,19)",C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])O)Cl)F,ODEICIIOTUWISY-UHFFFAOYSA-N,4-(3-chloro-4-fluoroanilino)-6-nitroquinazolin-7-ol,334.0268960,334.0268960,0,1,0,0,0,0,0,0,0,0,15,4,"",Classification|Patents,2,"",20190126,"A2B Chem|AiFChem, an XtalPi Company|BLD Pharm|BOC Sciences|FDA Global Substance Registration System (GSRS)|Google Patents|Molport|PATENTSCOPE (WIPO)|SureChEMBL|Synthonix, Inc.",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
138467463,"(S,E)-4-(Dimethylamino)-N-(4-((4-fluorophenyl)amino)-7-((tetrahydrofuran-3-YL)oxy)quinazolin-6-YL)but-2-enamide","Afatinib Impurity 18|2413212-25-4|(S,E)-4-(DIMETHYLAMINO)-N-(4-((4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)BUT-2-ENAMIDE|3-Dechloro Afatinib|UKS6N2Y9DL|SCHEMBL20812602|CS-0164280|E82039|(2E)-4-(Dimethylamino)-N-[4-[(4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide|(E)-4-(dimethylamino)-N-[4-(4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide|(S,E)-4-(Dimethylamino)-N-(4-((4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity)|2-Butenamide, 4-(dimethylamino)-N-[4-[(4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-, (2E)-",451.500,C24H26FN5O3,88.600,658.000,3.000,33,2,8,8,"InChI=1S/C24H26FN5O3/c1-30(2)10-3-4-23(31)29-21-12-19-20(13-22(21)33-18-9-11-32-14-18)26-15-27-24(19)28-17-7-5-16(25)6-8-17/h3-8,12-13,15,18H,9-11,14H2,1-2H3,(H,29,31)(H,26,27,28)/b4-3+/t18-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)F)O[C@H]4CCOC4,VZZYXLOQECVTHZ-WHLIDYPQSA-N,(E)-4-(dimethylamino)-N-[4-(4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide,451.20196787,451.20196787,0,1,0,1,1,0,1,1,0,0,9,4,"",Classification|Patents,2,"",20190720,"AbaChemScene|Acmec Biochemical|AstaTech, Inc.|BLD Pharm|BOC Sciences|CymitQuimica|EvitaChem|FDA Global Substance Registration System (GSRS)|LGC Standards|Mcule|Molport|PATENTSCOPE (WIPO)|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
22225700,"(R)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine","N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine|1621426-29-6|Afatinib Impurity B|(R)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine|MFCD18642925|Afatinib-des(4-dimethylamino-2-en-1-oxo)butyl|SCHEMBL1190516|6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydro-3-furanyl]oxy]quinazoline|N4-(3-Chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine|BCP27819|CRA85503|AKOS032947561|SB12232|SY028102|4-N-(3-chloro-4-fluorophenyl)-7-(oxolan-3-yloxy)quinazoline-4,6-diamine|N4-(3-chloro-4-fluoro-phenyl)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazoline-4,6-diamine",374.800,C18H16ClFN4O2,82.300,476.000,3.500,26,2,7,4,"InChI=1S/C18H16ClFN4O2/c19-13-5-10(1-2-14(13)20)24-18-12-6-15(21)17(7-16(12)22-9-23-18)26-11-3-4-25-8-11/h1-2,5-7,9,11H,3-4,8,21H2,(H,22,23,24)",C1COCC1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N,BIQABKFYKJRXII-UHFFFAOYSA-N,"4-N-(3-chloro-4-fluorophenyl)-7-(oxolan-3-yloxy)quinazoline-4,6-diamine",374.0945816,374.0945816,0,1,0,1,0,1,0,0,0,0,73,20,"",Classification|Patents,2,"",20071205,"10X CHEM|4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|Accela ChemBio Inc.|AKos Consulting & Solutions|Amfluoro|Ark Pharm, Inc.|Ark Pharma Scientific Limited|BioChemPartner|Biocore|Biosynth|BLD Pharm|BOC Sciences|CAPOT|Chem-Space.com Database|Clearsynth|Cooke Chemical Co., Ltd|eMolecules|EvitaChem|Google Patents|Hairui Chemical|IBM|Mcule|MolCore|Molport|PATENTSCOPE (WIPO)|Pi Chemicals|Starshine Chemical|SureChEMBL|Synblock Inc|Wubei-Biochem",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
66936816,"4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3R)-tetrahydro-3-furanyl]oxy]-","402855-07-6|(R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine|4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3R)-tetrahydro-3-furanyl]oxy]-|N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3R)-oxolan-3-yl]oxyquinazolin-4-amine|N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3R)-oxolan-3-yloxy]quinazolin-4-amine|Afatinib Impurity A|SCHEMBL1191541|UXAZURVGMXJLSO-LLVKDONJSA-N|AKOS030525402|X5337A22C5|CS-0164320|4-[(3-chloro-4-fluorophenyl)amino]-6-nitro-7-((R)-tetrahydrofuran-3-yloxy)quinazoline|N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[[(3R)-tetrahydro-3-furanyl]oxy]-4-quinazolinamine|(R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine (Afatinib Impurity)",404.800,C18H14ClFN4O4,102.000,556.000,4.000,28,1,8,4,"InChI=1S/C18H14ClFN4O4/c19-13-5-10(1-2-14(13)20)23-18-12-6-16(24(25)26)17(7-15(12)21-9-22-18)28-11-3-4-27-8-11/h1-2,5-7,9,11H,3-4,8H2,(H,21,22,23)/t11-/m1/s1",C1COC[C@@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)[N+](=O)[O-],UXAZURVGMXJLSO-LLVKDONJSA-N,N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3R)-oxolan-3-yl]oxyquinazolin-4-amine,404.0687608,404.0687608,0,1,0,1,1,0,0,0,0,0,32,4,"",Classification|Patents,2,"",20121130,"001Chemical|A2B Chem|AbaChemScene|Achemo Scientific Limited|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Amadis Chemical|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|CymitQuimica|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|Lan Pharmatech|LGC Standards|Mcule|NextMove Software|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
59504961,(2Z)-4-(dimethylamino)but-2-enoic acid,"1092365-58-6|(2Z)-4-(dimethylamino)but-2-enoic acid|CB8Z25S3EA|(z)-4-(dimethylamino)but-2-enoic acid|(2Z)-4-(Dimethylamino)-2-butenoic acid|2-Butenoic acid, 4-(dimethylamino)-, (2Z)-|UNII-CB8Z25S3EA|SCHEMBL3706927|ITGIYLMMAABTHC-ARJAWSKDSA-N|(z)-4-(dimethylamino)but-2-enoicacid|CS-0164231|EN300-365828|G74475|(2Z)-4-(Dimethylamino)-2-butenoic Acid (Afatinib Impurity pound(c)",129.160,C6H11NO2,40.500,118.000,-2.200,9,1,3,3,"InChI=1S/C6H11NO2/c1-7(2)5-3-4-6(8)9/h3-4H,5H2,1-2H3,(H,8,9)/b4-3-",CN(C)C/C=C\C(=O)O,ITGIYLMMAABTHC-ARJAWSKDSA-N,(Z)-4-(dimethylamino)but-2-enoic acid,129.078978594,129.078978594,0,1,0,0,0,0,1,1,0,0,18,6,"",Classification|Patents,2,"",20120820,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|AiFChem, an XtalPi Company|AstaTech, Inc.|BenchChem|BLD Pharm|Chem-Space.com Database|Chemenu Inc.|ChemIDplus|CymitQuimica|eMolecules|Enamine|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|LabNetwork, a WuXi AppTec Company|LGC Standards|Molport|NextMove Software|PATENTSCOPE (WIPO)|PubChem Reference Collection|SCRIPDB|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
154631185,"4-N-(4-chloro-3-fluorophenyl)-7-fluoroquinazoline-4,6-diamine","CS-0164286|N4-(4-chloro-3-fluorophenyl)-7-fluoroquinazoline-4,6-diamine? (Afatinib Impurity pound(c)",306.700,C14H9ClF2N4,63.800,362.000,3.600,21,2,6,2,"InChI=1S/C14H9ClF2N4/c15-9-2-1-7(3-10(9)16)21-14-8-4-12(18)11(17)5-13(8)19-6-20-14/h1-6H,18H2,(H,19,20,21)",C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)N)F)F)Cl,MINHFEJHRAVKTD-UHFFFAOYSA-N,"4-N-(4-chloro-3-fluorophenyl)-7-fluoroquinazoline-4,6-diamine",306.0483803,306.0483803,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
86662505,(E)-ethyl 4-(dimethylamino)but-2-enoate hydrochloride,"1255078-56-8|(E)-ethyl 4-(dimethylamino)but-2-enoate hydrochloride|ethyl (2E)-4-(dimethylamino)but-2-enoate hydrochloride|A6GR9RT3TC|ethyl (E)-4-(dimethylamino)but-2-enoate;hydrochloride|Ethyl (2E)-4-(dimethylamino)-2-butenoate hydrochloride|2-Butenoic acid, 4-(dimethylamino)-, ethyl ester, hydrochloride (1:1), (2E)-|Ethyl 4-(dimethylamino)but-2-enoate hydrochloride|UNII-A6GR9RT3TC|SCHEMBL665362|SCHEMBL665363|ZNMPTBLKKYPKMP-IPZCTEOASA-N|CS-0164312|EN300-736085|G37381|Ethyl(E)-4-(dimethylamino)but-2-enoatehydrochloride|Ethyl (E)-4-(dimethylamino)but-2-enoate hydrochloride|(E)-ethyl 4-(dimethylamino)but-2-enoate hydrochloride? (Afatinib Impurity pound(c)",193.670,C8H16ClNO2,29.500,141.000,"",12,1,3,5,"InChI=1S/C8H15NO2.ClH/c1-4-11-8(10)6-5-7-9(2)3;/h5-6H,4,7H2,1-3H3;1H/b6-5+;",CCOC(=O)/C=C/CN(C)C.Cl,ZNMPTBLKKYPKMP-IPZCTEOASA-N,ethyl (E)-4-(dimethylamino)but-2-enoate;hydrochloride,193.0869564,193.0869564,0,2,0,0,0,0,1,1,0,0,5,1,"",Classification|Patents,2,"",20150202,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|AppChem|AstaTech, Inc.|BenchChem|BePharm Ltd.|BLD Pharm|Chem-Space.com Database|Chemenu Inc.|ChemIDplus|eMolecules|Enamine|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|Molport|NextMove Software|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
22466739,(E)-4-(Methylamino)but-2-enoic acid,69169-63-7|(E)-4-(Methylamino)but-2-enoic acid|SCHEMBL4964694|SCHEMBL4964702|(E)-4-(Methylamino)but-2-enoicacid|AKOS006372779|(2E)-4-(methylamino)but-2-enoic acid|CS-0164242|EN300-7464794|(E)- 4-(Methylamino)-2-butenoic Acid (Afatinib Impurity pound(c),115.130,C5H9NO2,49.300,98.600,-2.700,8,2,3,3,"InChI=1S/C5H9NO2/c1-6-4-2-3-5(7)8/h2-3,6H,4H2,1H3,(H,7,8)/b3-2+",CNC/C=C/C(=O)O,NWVCFCJOJVDBHH-NSCUHMNNSA-N,(E)-4-(methylamino)but-2-enoic acid,115.063328530,115.063328530,0,1,0,0,0,0,1,1,0,0,12,7,"",Patents|Spectral Information,2,"",20071205,"10X CHEM|A2B Chem|AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Ambinter|AppChem|BLD Pharm|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Enamine|eNovation Chemicals|Google Patents|Molport|PATENTSCOPE (WIPO)|Starshine Chemical|SureChEMBL|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
11355577,Isopropyl chloro(oxo)acetate,"Isopropyl chloro(oxo)acetate|26404-20-6|isopropyl 2-chloro-2-oxoacetate|Acetic acid, 2-chloro-2-oxo-, 1-methylethyl ester|propan-2-yl 2-chloro-2-oxoacetate|SCHEMBL834672|APGNIJXHGYDYLS-UHFFFAOYSA-N|Chloro-oxo-acetic Acid Isopropyl Ester|CS-0164313|E73754|isopropyl 2-chloro-2-oxoacetate? (Afatinib Impurity pound(c)",150.560,C5H7ClO3,43.400,130.000,1.900,9,0,3,3,"InChI=1S/C5H7ClO3/c1-3(2)9-5(8)4(6)7/h3H,1-2H3",CC(C)OC(=O)C(=O)Cl,APGNIJXHGYDYLS-UHFFFAOYSA-N,propan-2-yl 2-chloro-2-oxoacetate,150.0083718,150.0083718,0,1,0,0,0,0,0,0,0,0,166,41,"",Literature|Patents,2,"",20061026,"A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|AstaTech, Inc.|BenchChem|BLD Pharm|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Google Patents|IBM|iChemical Technology USA Inc|Molport|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|SureChEMBL|Thomson Pharma|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
125274051,"N-(3,4-dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine","N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine|2512206-82-3|CS-0164275|N-(3,4-dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine? (Afatinib Impurity pound(c)|942-240-7",353.100,C14H7Cl2FN4O2,83.600,441.000,4.600,23,1,6,2,"InChI=1S/C14H7Cl2FN4O2/c15-9-2-1-7(3-10(9)16)20-14-8-4-13(21(22)23)11(17)5-12(8)18-6-19-14/h1-6H,(H,18,19,20)",C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F)Cl)Cl,BZUFBRLIMSOXIS-UHFFFAOYSA-N,"N-(3,4-dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine",351.9930090,351.9930090,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Safety and Hazards,2,"",20170410,A2B Chem|AbaChemScene|BLD Pharm|BOC Sciences|LGC Standards|MolGenie|PubChem Reference Collection,Chemical Vendors|Governmental Organizations|Research and Development,""
163197479,"N-(3,4-difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine","N-(3,4-Difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine|DZRYHCITHKPDFS-UHFFFAOYSA-N|CS-0164298|N-(3,4-difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine? (Afatinib Impurity pound(c)|2226537-61-5|942-239-1",320.230,C14H7F3N4O2,83.600,439.000,3.500,23,1,8,2,"InChI=1S/C14H7F3N4O2/c15-9-2-1-7(3-10(9)16)20-14-8-4-13(21(22)23)11(17)5-12(8)18-6-19-14/h1-6H,(H,18,19,20)",C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F)F)F,DZRYHCITHKPDFS-UHFFFAOYSA-N,"N-(3,4-difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine",320.05210997,320.05210997,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Safety and Hazards,2,"",20220430,AbaChemScene|BLD Pharm|MolGenie|PubChem Reference Collection,Chemical Vendors|Governmental Organizations|Research and Development,""
154631190,"N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3,4-bis(dimethylamino)butanamide","N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3,4-bis(dimethylamino)butanamide|CS-0164228|2414260-31-2|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3,4-bis(dimethylamino)butanamide (Afatinib Impurity)",531.000,C26H32ClFN6O3,91.900,736.000,3.400,37,2,9,10,"InChI=1S/C26H32ClFN6O3/c1-33(2)13-17(34(3)4)10-25(35)32-23-11-19-22(12-24(23)37-18-7-8-36-14-18)29-15-30-26(19)31-16-5-6-21(28)20(27)9-16/h5-6,9,11-12,15,17-18H,7-8,10,13-14H2,1-4H3,(H,32,35)(H,29,30,31)/t17?,18-/m0/s1",CN(C)CC(CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)N(C)C,VZAJTMWUJFLJIB-ZVAWYAOSSA-N,"N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3,4-bis(dimethylamino)butanamide",530.2208448,530.2208448,0,1,0,2,1,1,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|PATENTSCOPE (WIPO)",Chemical Vendors|Governmental Organizations,""
154631207,7-Fluoro-6-nitro-4-propan-2-yloxyquinazoline,CS-0164273|7-fluoro-4-isopropoxy-6-nitroquinazoline? (Afatinib Impurity pound(c),251.210,C11H10FN3O3,80.800,310.000,2.600,18,0,6,2,"InChI=1S/C11H10FN3O3/c1-6(2)18-11-7-3-10(15(16)17)8(12)4-9(7)13-5-14-11/h3-6H,1-2H3",CC(C)OC1=NC=NC2=CC(=C(C=C21)[N+](=O)[O-])F,DWVSWSPQFJGOPW-UHFFFAOYSA-N,7-fluoro-6-nitro-4-propan-2-yloxyquinazoline,251.07061935,251.07061935,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
7021876,Boc-D-Arg(NO2)-OH,"Boc-D-Arg(NO2)-OH|50913-12-7|Nalpha-Boc-Nomega-nitro-D-arginine|(2R)-5-[[amino(nitramido)methylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid|N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine|boc-nw-nitro-d-arginine|Na-Boc-N?-nitro-D-arginine|(2R)-5-[amino(nitramido)methylidene]azaniumyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate|MFCD00038091|(2R)-2-{[(tert-butoxy)carbonyl]amino}-5-(N'-nitrocarbamimidamido)pentanoic acid|Boc-D-Arg(NO)-OH|CID 7021875|N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-D-ornithine; Na-Boc-Nw-nitro-D-arginine; Boc-D-Arg(NO2)-OH;|Boc-D-Nitroarginine|Boc-D-Arg (NO2)-OH|Boc-D-Arg-(NO2)-OH|SCHEMBL20542979|DTXSID00427410|OZSSOVRIEPAIMP-SSDOTTSWSA-N|9Q358K64GP|AKOS024256803|AS-31731|CS-0164323|EN300-7358445|N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-D-ornithine|(R)-N5 -[amino(nitroimino)methyl]-N2 -[(1,1-dimethylethoxy)-carbonyl]-ornithine|(R)-N5 -[amino(nitroimino)methyl]-N2 -[(1,1-dimethylethoxy)carbonyl]-ornithine|D-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-|N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[imino(nitroamino)methyl]-D-ornithine (Afatinib Impurity pound(c)",319.310,C11H21N5O6,172.000,439.000,0.300,22,4,7,9,"InChI=1S/C11H21N5O6/c1-11(2,3)22-10(19)14-7(8(17)18)5-4-6-13-9(12)15-16(20)21/h7H,4-6H2,1-3H3,(H,14,19)(H,17,18)(H3,12,13,15)/t7-/m1/s1",CC(C)(C)OC(=O)N[C@H](CCCN=C(N)N[N+](=O)[O-])C(=O)O,OZSSOVRIEPAIMP-SSDOTTSWSA-N,(2R)-5-[[amino(nitramido)methylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid,319.14918341,319.14918341,0,1,0,1,1,0,0,0,0,0,20,8,"",Classification|Patents,2,"",20060729,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Accel Scientific|Achemtek|Acmec Biochemical|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|AppChem|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|BenchChem|Bic Biotech|BioCrick|BLD Pharm|BOC Sciences|ChangChem|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Combi-Blocks|CreativePeptides|CymitQuimica|eMolecules|Enamine|eNovation Chemicals|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou Trylead Chemical Technology|IBM|InvivoChem|J&H Chemical Co.,ltd|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LGC Standards|Matrix Scientific|Mcule|Molport|MuseChem|NextBio|NextMove Software|PATENTSCOPE (WIPO)|R&D Chemicals|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Smolecule|SureChEMBL|SynHet - Synthetic Heterocycles|THE BioTek|Tractus|Win-Win Chemical|Wubei-Biochem|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
3432354,Ethyl 4-bromo-3-hydroxybutanoate,ethyl 4-bromo-3-hydroxybutanoate|ethyl 4-bromo-3-hydroxybutyrate|32224-01-4|95310-48-8|4-bromo-3-hydroxybutanoic acid ethyl ester|95310-94-4|(R)-Ethyl 4-bromo-3-hydroxybutanoate|SCHEMBL606889|AIZRKZQHJNWBEI-UHFFFAOYSA-N|ethyl 4-bromo-3-hydroxy-butanoate|DB-057588|CS-0164317|ethyl 4-bromo-3-hydroxybutanoate? (Afatinib Impurity pound(c),211.050,C6H11BrO3,46.500,105.000,0.600,10,1,3,5,"InChI=1S/C6H11BrO3/c1-2-10-6(9)3-5(8)4-7/h5,8H,2-4H2,1H3",CCOC(=O)CC(CBr)O,AIZRKZQHJNWBEI-UHFFFAOYSA-N,ethyl 4-bromo-3-hydroxybutanoate,209.98916,209.98916,0,1,0,1,0,1,0,0,0,1,122,34,"",Literature|Patents,2,"",20050908,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|Achemica|AHH Chemical co.,ltd|AiFChem, an XtalPi Company|Alfa Chemistry|Amadis Chemical|Ambinter|BenchChem|BLD Pharm|BOC Sciences|Chem-Impex|ChemDB|ChemSpider|Clearsynth|Debye Scientific Co., Ltd|DiscoveryGate|EvitaChem|Google Patents|Hairui Chemical|IBM|MolCore|NextBio|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
66584354,"N4-(3-chloro-4-fluorophenyl)-7-ethoxyquinazoline-4,6-diamine","1269662-90-9|N4-(3-Chloro-4-fluorophenyl)-7-ethoxyquinazoline-4,6-diamine (Afatinib Impurity)|N4-(3-chloro-4-fluorophenyl)-7-ethoxyquinazoline-4,6-diamine|SCHEMBL26637|PDLCDTRXIQXHIL-UHFFFAOYSA-N|DB-109917|CS-0200326|F82979",332.760,C16H14ClFN4O,73.100,391.000,3.800,23,2,6,4,"InChI=1S/C16H14ClFN4O/c1-2-23-15-7-14-10(6-13(15)19)16(21-8-20-14)22-9-3-4-12(18)11(17)5-9/h3-8H,2,19H2,1H3,(H,20,21,22)",CCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)N,PDLCDTRXIQXHIL-UHFFFAOYSA-N,"4-N-(3-chloro-4-fluorophenyl)-7-ethoxyquinazoline-4,6-diamine",332.0840169,332.0840169,0,1,0,0,0,0,0,0,0,0,49,8,"",Classification|Patents,2,"",20121130,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|Acmec Biochemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|Debye Scientific Co., Ltd|eNovation Chemicals|Google Patents|IBM|Mcule|Molport|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
127255551,4-Chloro-7-fluoroquinazolin-6-amine,4-Chloro-7-fluoroquinazolin-6-amine|1260808-58-9|CS-0164284|4-chloro-7-fluoroquinazolin-6-amine? (Afatinib Impurity pound(c),197.600,C8H5ClFN3,51.800,192.000,1.900,13,1,4,0,"InChI=1S/C8H5ClFN3/c9-8-4-1-6(11)5(10)2-7(4)12-3-13-8/h1-3H,11H2",C1=C2C(=CC(=C1N)F)N=CN=C2Cl,ZJEWIJQIYIKEFK-UHFFFAOYSA-N,4-chloro-7-fluoroquinazolin-6-amine,197.0156030,197.0156030,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20170618,"001Chemical|AbaChemScene|AiFChem, an XtalPi Company|Ambinter|BLD Pharm|Chemenu Inc.|MolCore|PATENTSCOPE (WIPO)|Starshine Chemical",Chemical Vendors|Governmental Organizations,""
87646528,(3S)-4-Chloro-3-hydroxybutanal,(s)-4-chloro-3-hydroxybutanal|(3S)-4-chloro-3-hydroxybutanal|125781-04-6|SCHEMBL4285960|DTXSID901305856|CS-0164310|(S)-4-chloro-3-hydroxybutanal? (Afatinib Impurity pound(c),122.550,C4H7ClO2,37.300,55.700,-0.400,7,1,2,3,"InChI=1S/C4H7ClO2/c5-3-4(7)1-2-6/h2,4,7H,1,3H2/t4-/m0/s1",C(C=O)[C@@H](CCl)O,XQXWWWKGIMBNKZ-BYPYZUCNSA-N,(3S)-4-chloro-3-hydroxybutanal,122.0134572,122.0134572,0,1,0,1,1,0,0,0,0,3,4,2,"",Literature|Patents,2,"",20150212,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|EPA DSSTox|Google Patents|PATENTSCOPE (WIPO)|PubChem Reference Collection|Springer Nature|SureChEMBL|Thieme Chemistry",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,""
13963152,(S)-3-((tert-Butyldimethylsilyl)oxy)-4-chlorobutanal,"(S)-3-((tert-Butyldimethylsilyl)oxy)-4-chlorobutanal|119136-85-5|SCHEMBL1690710|UTZDSSCUZVIWQI-VIFPVBQESA-N|CS-0164230|(S)-3-(tert-Butyldimethylsilyloxy)-4-chlorobutanal|(3S)-4-Chloro-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-butanal (Afatinib Impurity pound(c)",236.810,C10H21ClO2Si,26.300,187.000,"",14,0,2,6,"InChI=1S/C10H21ClO2Si/c1-10(2,3)14(4,5)13-9(8-11)6-7-12/h7,9H,6,8H2,1-5H3/t9-/m0/s1",CC(C)(C)[Si](C)(C)O[C@@H](CC=O)CCl,UTZDSSCUZVIWQI-VIFPVBQESA-N,(3S)-3-[tert-butyl(dimethyl)silyl]oxy-4-chlorobutanal,236.0999341,236.0999341,0,1,0,1,1,0,0,0,0,0,19,1,"",Patents|Spectral Information,2,"",20070208,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|Google Patents|IBM|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
154631183,7-Fluoro-4-propan-2-yloxyquinazolin-6-amine,CS-0164283|7-fluoro-4-isopropoxyquinazolin-6-amine? (Afatinib Impurity pound(c),221.230,C11H12FN3O,61.000,239.000,2.100,16,1,5,2,"InChI=1S/C11H12FN3O/c1-6(2)16-11-7-3-9(13)8(12)4-10(7)14-5-15-11/h3-6H,13H2,1-2H3",CC(C)OC1=NC=NC2=CC(=C(C=C21)N)F,IIIAYLNJMIZNCJ-UHFFFAOYSA-N,7-fluoro-4-propan-2-yloxyquinazolin-6-amine,221.09644018,221.09644018,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
154631199,7-fluoro-4-[(3S)-oxolan-3-yl]oxyquinazolin-6-amine,CS-0164285|(S)-7-fluoro-4-((tetrahydrofuran-3-yl)oxy)quinazolin-6-amine? (Afatinib Impurity pound(c),249.240,C12H12FN3O2,70.300,294.000,1.300,18,1,6,2,"InChI=1S/C12H12FN3O2/c13-9-4-11-8(3-10(9)14)12(16-6-15-11)18-7-1-2-17-5-7/h3-4,6-7H,1-2,5,14H2/t7-/m0/s1",C1COC[C@H]1OC2=NC=NC3=CC(=C(C=C32)N)F,GFTBVAYMUSSLSE-ZETCQYMHSA-N,7-fluoro-4-[(3S)-oxolan-3-yl]oxyquinazolin-6-amine,249.09135480,249.09135480,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
154631200,"4-N-(3,4-dichlorophenyl)-7-fluoroquinazoline-4,6-diamine","CS-0164287|N4-(3,4-dichlorophenyl)-7-fluoroquinazoline-4,6-diamine? (Afatinib Impurity pound(c)",323.100,C14H9Cl2FN4,63.800,362.000,4.100,21,2,5,2,"InChI=1S/C14H9Cl2FN4/c15-9-2-1-7(3-10(9)16)21-14-8-4-12(18)11(17)5-13(8)19-6-20-14/h1-6H,18H2,(H,19,20,21)",C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)N)F)Cl)Cl,UJATVUALZDQBFR-UHFFFAOYSA-N,"4-N-(3,4-dichlorophenyl)-7-fluoroquinazoline-4,6-diamine",322.0188299,322.0188299,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
9920488,"2-Piperidinecarboxylic acid, 4-methyl-, ethyl ester, (2S-cis)-","79199-62-5|Ethyl (2S,4R)-4-Methylpipecolate|(2S,4R)-Ethyl 4-methylpiperidine-2-carboxylate|ethyl (2S,4R)-4-methylpiperidine-2-carboxylate|(2S-cis)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester|2-Piperidinecarboxylic acid, 4-methyl-, ethyl ester, (2S-cis)-|(2S,4R)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester; (2S-cis)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester;|starbld0017180|DTXSID901179419|DB-254640|CS-0163976|F78215|EN300-23006207|rac-ethyl (2R,4S)-4-methylpiperidine-2-carboxylate|(2S-cis)-4-Methyl-2-piperidineCarboxylic Acid Ethyl Ester (Afatinib Impurity pound(c)",171.240,C9H17NO2,38.300,159.000,1.400,12,1,3,3,"InChI=1S/C9H17NO2/c1-3-12-9(11)8-6-7(2)4-5-10-8/h7-8,10H,3-6H2,1-2H3/t7-,8+/m1/s1",CCOC(=O)[C@@H]1C[C@@H](CCN1)C,GHBNOCBWSUHAAA-SFYZADRCSA-N,"ethyl (2S,4R)-4-methylpiperidine-2-carboxylate",171.125928785,171.125928785,0,1,0,2,2,0,0,0,0,0,0,0,"",Patents|Spectral Information,2,"",20061025,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|Amadis Chemical|AppChem|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|Enamine|eNovation Chemicals|EPA DSSTox|EvitaChem|Finetech Industry Limited|iChemical Technology USA Inc|LabNetwork, a WuXi AppTec Company|LGC Standards|Mcule|Molport|MuseChem|NextBio|PATENTSCOPE (WIPO)|PubChem Reference Collection|RR Scientific|Starshine Chemical|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
66936486,"(R)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine","402855-03-2|(R)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine|4-N-(3-chloro-4-fluorophenyl)-7-[(3R)-oxolan-3-yl]oxyquinazoline-4,6-diamine|4,6-Quinazolinediamine, N4-(3-chloro-4-fluorophenyl)-7-[[(3R)-tetrahydro-3-furanyl]oxy]-|(R)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine|C18H16ClFN4O2|KZ9K45W6RE|SCHEMBL1190518|BIQABKFYKJRXII-LLVKDONJSA-N|CS-0164321|E82041|6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-((R)-tetrahydrofuran-3-yloxy)quinazoline|N4-(3-chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine, (R)-|N4-(3-Chloro-4-fluorophenyl)-7-[[(3R)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine|(R)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine (Afatinib Impurity)",374.800,C18H16ClFN4O2,82.300,476.000,3.500,26,2,7,4,"InChI=1S/C18H16ClFN4O2/c19-13-5-10(1-2-14(13)20)24-18-12-6-15(21)17(7-16(12)22-9-23-18)26-11-3-4-25-8-11/h1-2,5-7,9,11H,3-4,8,21H2,(H,22,23,24)/t11-/m1/s1",C1COC[C@@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N,BIQABKFYKJRXII-LLVKDONJSA-N,"4-N-(3-chloro-4-fluorophenyl)-7-[(3R)-oxolan-3-yl]oxyquinazoline-4,6-diamine",374.0945816,374.0945816,0,1,0,1,1,0,0,0,0,0,31,5,"",Classification|Patents,2,"",20121130,"001Chemical|AbaChemScene|Acmec Biochemical|Amadis Chemical|Angene Chemical|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|CymitQuimica|eMolecules|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|Lan Pharmatech|Matrix Scientific|Mcule|Molport|NextMove Software|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thoreauchem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
11320970,(s)-4-Chloro-3-hydroxybutyric acid,(s)-4-chloro-3-hydroxybutyric acid|106941-19-9|(3S)-4-CHLORO-3-HYDROXYBUTANOIC ACID|(s)-4-chloro-3-hydroxybutanoic acid|SCHEMBL1405707|CS-0164309|(S)-4-chloro-3-hydroxybutanoic acid? (Afatinib Impurity pound(c),138.550,C4H7ClO3,57.500,83.400,-0.300,8,2,3,3,"InChI=1S/C4H7ClO3/c5-2-3(6)1-4(7)8/h3,6H,1-2H2,(H,7,8)/t3-/m0/s1",C([C@@H](CCl)O)C(=O)O,AKDAXGMVRMXFOO-VKHMYHEASA-N,(3S)-4-chloro-3-hydroxybutanoic acid,138.0083718,138.0083718,0,1,0,1,1,0,0,0,0,4,104,56,"",Literature|Patents,2,"",20061026,"001Chemical|AbaChemScene|AHH Chemical co.,ltd|AiFChem, an XtalPi Company|Amadis Chemical|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chemenu Inc.|ChemSpider|ChemTik|CymitQuimica|DiscoveryGate|EvitaChem|Google Patents|IBM|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|PATENTSCOPE (WIPO)|Rare Chemicals GmbH, Germany|RR Scientific|SCRIPDB|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
136478438,(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide,(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide|SCHEMBL13083349|2223677-61-8|CS-0164229|(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity pound(c),415.800,C20H19ClFN5O2,90.400,581.000,3.300,29,3,7,6,"InChI=1S/C20H19ClFN5O2/c1-27(2)7-3-4-19(29)26-17-9-13-16(10-18(17)28)23-11-24-20(13)25-12-5-6-15(22)14(21)8-12/h3-6,8-11,28H,7H2,1-2H3,(H,26,29)(H,23,24,25)/b4-3+",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O,VOPXRQCNCZEDLI-ONEGZZNKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-hydroxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,415.1211307,415.1211307,0,1,0,0,0,0,1,1,0,0,32,18,"",Classification|Patents,2,"",20190123,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|BOC Sciences|Google Patents|PATENTSCOPE (WIPO)|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
154631194,1-[4-(3-chloro-4-fluoroanilino)-1-oxido-7-[(3S)-oxolan-3-yl]oxyquinazolin-1-ium-6-yl]-5-hydroxypyrrolidin-2-one,CS-0164281|4-((3-chloro-4-fluorophenyl)amino)-6-(2-hydroxy-5-oxopyrrolidin-1-yl)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazoline 1-oxide? (Afatinib Impurity pound(c),474.900,C22H20ClFN4O5,109.000,710.000,2.100,33,2,8,5,"InChI=1S/C22H20ClFN4O5/c23-15-7-12(1-2-16(15)24)26-22-14-8-18(28-20(29)3-4-21(28)30)19(33-13-5-6-32-10-13)9-17(14)27(31)11-25-22/h1-2,7-9,11,13,20,29H,3-6,10H2,(H,25,26)/t13-,20?/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)[N+](=CN=C3NC4=CC(=C(C=C4)F)Cl)[O-])N5C(CCC5=O)O,HMAKUGDWZGOXDX-SZQRVLIRSA-N,1-[4-(3-chloro-4-fluoroanilino)-1-oxido-7-[(3S)-oxolan-3-yl]oxyquinazolin-1-ium-6-yl]-5-hydroxypyrrolidin-2-one,474.1106256,474.1106256,0,1,0,2,1,1,0,0,0,0,0,0,"",Classification|Patents,2,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
163197462,"(S)-N1-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-N2,N2-dimethyloxalamide (Afatinib Impurity","2223677-66-3|(S)-N1-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-N2,N2-dimethyloxalamide (Afatinib Impurity|(S)-N1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-N2,N2-DIMETHYLOXALAMIDE|Afatinib Impurity CSEJXA|ZEB2BWA4FQ|Afatinib  Impurity CSEJXA|CS-0164258|E82032|(S)-N1-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-N2,N2-dimethyloxalamide (Afatinib Impurity pound(c)|(S)-N1-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-N2,N2-dimethyloxalamide (Afatinib Impurity?|Ethanediamide, N2-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-N1,N1-dimethyl-|N2-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-N1,N1-dimethylethanediamide",473.900,C22H21ClFN5O4,106.000,704.000,3.200,33,2,8,5,"InChI=1S/C22H21ClFN5O4/c1-29(2)22(31)21(30)28-18-8-14-17(9-19(18)33-13-5-6-32-10-13)25-11-26-20(14)27-12-3-4-16(24)15(23)7-12/h3-4,7-9,11,13H,5-6,10H2,1-2H3,(H,28,30)(H,25,26,27)/t13-/m0/s1",CN(C)C(=O)C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,TXTARPMHKVXFGC-ZDUSSCGKSA-N,"N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-N',N'-dimethyloxamide",473.1266100,473.1266100,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220430,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Mcule|Molport|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
154631188,"(S,E)-N-(4-((3,4-Dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)","2223677-63-0|(S,E)-N-(4-((3,4-Dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)|(S,E)-N-(4-((3,4-DICHLOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE|2-Chloro-Afatinib|Afatinib Impurity SCl|KQ2BJM2JGT|CS-0164263|E82033|(2E)-N-[4-[(3,4-Dichlorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(E)-N-[4-(3,4-dichloroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|2-Butenamide, N-[4-[(3,4-dichlorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-",502.400,C24H25Cl2N5O3,88.600,700.000,4.200,34,2,7,8,"InChI=1S/C24H25Cl2N5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-18(25)19(26)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)Cl)O[C@H]4CCOC4,GMLBQFFEIVQHIS-CWDCEQMOSA-N,"(E)-N-[4-(3,4-dichloroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide",501.1334451,501.1334451,0,1,0,1,1,0,1,1,0,0,0,0,"",Patents,1,"",20200928,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|CymitQuimica|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
53254174,Afatinib-d6,Afatinib-d6|Afatinib D6|1313874-96-2|(E)-4-[bis(trideuteriomethyl)amino]-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide-d6; BIBW 2992-d6;|HY-10261S|AKOS040732393|1ST162749D6|DA-60829|CS-0019794|G16044,492.000,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1/i1D3,2D3",[2H]C([2H])([2H])N(C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)C([2H])([2H])[2H],ULXXDDBFHOBEHA-VCXSEIMGSA-N,(E)-4-[bis(trideuteriomethyl)amino]-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide,491.2006560,491.2006560,0,1,6,1,1,0,1,1,0,0,0,0,"",Literature,1,"",20110725,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Achemtek|AKos Consulting & Solutions|Alsachim|Amadis Chemical|AstaTech, Inc.|BenchChem|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|Clearsynth|CymitQuimica|Debye Scientific Co., Ltd|eNovation Chemicals|InvivoChem|LGC Standards|MedChemexpress MCE|Molport|MuseChem|Probes & Drugs portal|RR Scientific|Smolecule|TargetMol|THE BioTek|Thomson Pharma",Chemical Vendors|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
163197489,(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity),"2170273-17-1|(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-fluoro-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-FLUOROQUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE|Afatinib Impurity 9|V4BER825NH|CS-0164319|E82040|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-fluoroquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-fluoro-6-quinazolinyl]-4-(dimethylamino)-|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-fluoro-6-quinazolinyl]-4-(dimethylamino)-, (2E)-|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)but-2-enamide, (E)-|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-fluoro-6-quinazolinyl]-4-(dimethylamino)-2-butenamide",417.800,C20H18ClF2N5O,70.200,581.000,3.700,29,2,7,6,"InChI=1S/C20H18ClF2N5O/c1-28(2)7-3-4-19(29)27-18-9-13-17(10-16(18)23)24-11-25-20(13)26-12-5-6-15(22)14(21)8-12/h3-6,8-11H,7H2,1-2H3,(H,27,29)(H,24,25,26)/b4-3+",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)F,SNZIYDICMLMCLI-ONEGZZNKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-fluoroquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,417.1167942,417.1167942,0,1,0,0,0,0,1,1,0,0,0,0,"",Classification,1,"",20220430,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acmec Biochemical|Amadis Chemical|AppChem|AstaTech, Inc.|BLD Pharm|BOC Sciences|eNovation Chemicals|EvitaChem|FDA Global Substance Registration System (GSRS)|Mcule|Molport|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations,""
136295075,Afatinib Impurity J,"Afatinib Impurity J|1456696-14-2|(2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide|(S,E)-4-(DIMETHYLAMINO)-N-(4-HYDROXY-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)BUT-2-ENAMIDE|(S,e)-4-(dimethylamino)-N-(4-oxo-7-((tetrahydrofuran-3-yl)oxy)-3,4-dihydroquinazolin-6-yl)but-2-enamide|8P652B3QLZ|SCHEMBL17352060|SCHEMBL17352063|GSUSIQVMAQBROU-PCAWENJQSA-N|CS-0164268|E82037|(2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide; 2-Butenamide, N-[3,4-dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)- (ACI); (2E)-N-[3,4-Dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (ACI)|(S,E)-4-(Dimethylamino)-N-(4-hydroxy-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity)|2-Butenamide, N-[3,4-dihydro-4-oxo-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-",358.400,C18H22N4O4,92.300,578.000,0.200,26,2,6,6,"InChI=1S/C18H22N4O4/c1-22(2)6-3-4-17(23)21-15-8-13-14(19-11-20-18(13)24)9-16(15)26-12-5-7-25-10-12/h3-4,8-9,11-12H,5-7,10H2,1-2H3,(H,21,23)(H,19,20,24)/b4-3+/t12-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=O)NC=N2)O[C@H]3CCOC3,GSUSIQVMAQBROU-PCAWENJQSA-N,(E)-4-(dimethylamino)-N-[4-oxo-7-[(3S)-oxolan-3-yl]oxy-3H-quinazolin-6-yl]but-2-enamide,358.16410520,358.16410520,0,1,0,1,1,0,1,1,0,0,2,1,"",Patents,1,"",20190123,"001Chemical|10X CHEM|A2B Chem|AbaChemScene|Accel Scientific|Acmec Biochemical|Amadis Chemical|AstaTech, Inc.|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|CymitQuimica|eMolecules|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|LGC Standards|Mcule|Molport|NextMove Software|Springer Nature|SureChEMBL|SynHet - Synthetic Heterocycles|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
121490264,Afatinib cysteinyl metabolite,"afatinib cysteinyl metabolite|AFATINIB METABOLITE M4|7M1HA8EU67|Q27268548|(2R)-2-AMINO-3-(3-((4-(3-CHLORO-4-FLUORO-ANILINO)-7-((3S)-TETRAHYDROFURAN-3-YL)OXY-QUINAZOLIN-6-YL)AMINO)-1-(DIMETHYLAMINOMETHYL)-3-OXO-PROPYL)SULFANYL-PROPANOIC ACID|2-AMINO-3-(3-((4-(3-CHLORO-4-FLUORO-ANILINO)-7-((3S)-TETRAHYDROFURAN-3-YL)OXY-QUINAZOLIN-6-YL)AMINO)-1-(DIMETHYLAMINOMETHYL)-3-OXO-PROPYL)SULFANYL-PROPANOIC ACID, (2R)-",607.100,C27H32ClFN6O5S,177.000,867.000,0.400,41,4,12,13,"InChI=1S/C27H32ClFN6O5S/c1-35(2)11-17(41-13-21(30)27(37)38)8-25(36)34-23-9-18-22(10-24(23)40-16-5-6-39-12-16)31-14-32-26(18)33-15-3-4-20(29)19(28)7-15/h3-4,7,9-10,14,16-17,21H,5-6,8,11-13,30H2,1-2H3,(H,34,36)(H,37,38)(H,31,32,33)/t16-,17?,21-/m0/s1",CN(C)CC(CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)SC[C@@H](C(=O)O)N,JWDZHSCYKMQHLE-RFXBXZJJSA-N,(2R)-2-amino-3-[4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-1-(dimethylamino)-4-oxobutan-2-yl]sulfanylpropanoic acid,606.1827452,606.1827452,0,1,0,3,2,1,0,0,0,0,0,0,"",Classification,1,"",20160816,"Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|FDA Global Substance Registration System (GSRS)",Curation Efforts|Governmental Organizations,""
171394605,"Des(N,N-Dimethylprop-2-enyl-1-Amine) Afatinib","Des(N,N-Dimethylprop-2-enyl-1-Amine) Afatinib|Des(4-dimethylamino-2-en-1-oxo)butyl Afatinib N6 Formyl",402.800,C19H16ClFN4O3,85.400,533.000,3.400,28,2,7,5,"InChI=1S/C19H16ClFN4O3/c20-14-5-11(1-2-15(14)21)25-19-13-6-17(24-10-26)18(7-16(13)22-9-23-19)28-12-3-4-27-8-12/h1-2,5-7,9-10,12H,3-4,8H2,(H,24,26)(H,22,23,25)/t12-/m1/s1",C1COC[C@@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC=O,ZBGVNMZERFYSES-GFCCVEGCSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[(3R)-oxolan-3-yl]oxyquinazolin-6-yl]formamide,402.0894962,402.0894962,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20240612,LGC Standards,Chemical Vendors,""
121489186,Afatinib cysteinyl acetate,afatinib cysteinyl acetate|0T85FU1PUZ|AFATINIB METABOLITE M13|Q27237228,649.100,C29H34ClFN6O6S,180.000,973.000,0.700,44,4,12,14,"InChI=1S/C29H34ClFN6O6S/c1-16(38)34-25(29(40)41)14-44-19(12-37(2)3)9-27(39)36-24-10-20-23(11-26(24)43-18-6-7-42-13-18)32-15-33-28(20)35-17-4-5-22(31)21(30)8-17/h4-5,8,10-11,15,18-19,25H,6-7,9,12-14H2,1-3H3,(H,34,38)(H,36,39)(H,40,41)(H,32,33,35)/t18-,19?,25-/m0/s1",CC(=O)N[C@@H](CSC(CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)CN(C)C)C(=O)O,IOLFYXZPZPSEJP-VJIXTZNPSA-N,(2R)-2-acetamido-3-[4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-1-(dimethylamino)-4-oxobutan-2-yl]sulfanylpropanoic acid,648.1933099,648.1933099,0,1,0,3,2,1,0,0,0,0,0,0,"",Classification,1,"",20160816,"Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|FDA Global Substance Registration System (GSRS)|Wikidata",Curation Efforts|Governmental Organizations,""
163197455,Afatinib Impurity AFT-8,Afatinib Impurity AFT-8|2323570-72-3|N-[4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutenamide;|CS-0164227|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide (Afatinib Impurity),504.000,C24H27ClFN5O4,109.000,694.000,3.200,35,3,9,9,"InChI=1S/C24H27ClFN5O4/c1-31(2)11-15(32)8-23(33)30-21-9-17-20(10-22(21)35-16-5-6-34-12-16)27-13-28-24(17)29-14-3-4-19(26)18(25)7-14/h3-4,7,9-10,13,15-16,32H,5-6,8,11-12H2,1-2H3,(H,30,33)(H,27,28,29)/t15?,16-/m0/s1",CN(C)CC(CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)O,IQINQKMQCQYKAD-LYKKTTPLSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)-3-hydroxybutanamide,503.1735602,503.1735602,0,1,0,2,1,1,0,0,0,0,0,0,"",Classification,1,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company|BOC Sciences|Clearsynth|LGC Standards",Chemical Vendors,""
168356172,3-Fluoro-Afatinib,"3-Fluoro-Afatinib|(E)-N-[4-(3,4-difluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|YND67762",469.500,C24H25F2N5O3,88.600,700.000,3.100,34,2,9,8,"InChI=1S/C24H25F2N5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-18(25)19(26)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)",CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)F)OC4CCOC4,HGIMFDMPTIPMFG-UHFFFAOYSA-N,"N-[4-(3,4-difluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide",469.19254600,469.19254600,0,1,0,1,0,1,1,0,1,0,0,0,"",Classification,1,"",20230711,"Biosynth|Cooke Chemical Co., Ltd|Mcule|MolCore",Chemical Vendors,""
169545053,(S)-Ethyl 2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoacetate (Afatinib Impurity),(S)-Ethyl 2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoacetate (Afatinib Impurity)|2803420-62-2,474.900,C22H20ClFN4O5,112.000,691.000,4.000,33,2,9,8,"InChI=1S/C22H20ClFN4O5/c1-2-32-22(30)21(29)28-18-8-14-17(9-19(18)33-13-5-6-31-10-13)25-11-26-20(14)27-12-3-4-16(24)15(23)7-12/h3-4,7-9,11,13H,2,5-6,10H2,1H3,(H,28,29)(H,25,26,27)",CCOC(=O)C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,ZXYDHJNWDIATAJ-UHFFFAOYSA-N,ethyl 2-[[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]amino]-2-oxoacetate,474.1106256,474.1106256,0,1,0,1,0,1,0,0,0,0,0,0,"",Classification,1,"",20240123,Amfluoro|MolCore,Chemical Vendors,""
125272208,Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib,Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib|2413212-09-4,356.800,C18H17ClN4O2,82.300,443.000,3.400,25,2,6,4,"InChI=1S/C18H17ClN4O2/c19-11-2-1-3-12(6-11)23-18-14-7-15(20)17(8-16(14)21-10-22-18)25-13-4-5-24-9-13/h1-3,6-8,10,13H,4-5,9,20H2,(H,21,22,23)/t13-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=CC=C4)Cl)N,VGCTYFLBQMFZEW-ZDUSSCGKSA-N,"4-N-(3-chlorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine",356.1040035,356.1040035,0,1,0,1,1,0,0,0,0,0,0,0,"",Patents,1,"",20170410,LGC Standards|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
125399330,"Deschloro,desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib","Deschloro,desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib",322.400,C18H18N4O2,82.300,404.000,2.800,24,2,6,4,"InChI=1S/C18H18N4O2/c19-15-8-14-16(9-17(15)24-13-6-7-23-10-13)20-11-21-18(14)22-12-4-2-1-3-5-12/h1-5,8-9,11,13H,6-7,10,19H2,(H,20,21,22)/t13-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC=CC=C4)N,MOKLODJQQQCQHF-ZDUSSCGKSA-N,"7-[(3S)-oxolan-3-yl]oxy-4-N-phenylquinazoline-4,6-diamine",322.14297583,322.14297583,0,1,0,1,1,0,0,0,0,0,0,0,"",Patents,1,"",20170410,LGC Standards|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
86710845,Afatinib Citrate,Afatinib Citrate|SVOSDJSPVQDKLI-KHNHNNODSA-K,675.000,C30H30ClFN5O10-3,229.000,912.000,"",47,3,15,10,"InChI=1S/C24H25ClFN5O3.C6H8O7/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b4-3+;/t16-;/m0./s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,SVOSDJSPVQDKLI-KHNHNNODSA-K,"(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide;2-hydroxypropane-1,2,3-tricarboxylate",674.1665230,674.1665230,-3,2,0,1,1,0,1,1,0,0,2,1,"",Patents,1,"",20150202,NextMove Software,Curation Efforts|Research and Development,""
169443566,"Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(pyrrolidin-2,5-dion-1-yl) Afatinib","Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(pyrrolidin-2,5-dion-1-yl) Afatinib",456.900,C22H18ClFN4O4,93.700,701.000,2.900,32,1,8,5,"InChI=1S/C22H18ClFN4O4/c23-15-7-12(1-2-16(15)24)27-22-14-8-18(28-20(29)3-4-21(28)30)19(9-17(14)25-11-26-22)32-13-5-6-31-10-13/h1-2,7-9,11,13H,3-6,10H2,(H,25,26,27)/t13-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N5C(=O)CCC5=O,LKZAKDSEOPUVGE-ZDUSSCGKSA-N,"1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]pyrrolidine-2,5-dione",456.1000609,456.1000609,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20231201,10X CHEM|A2B Chem|LGC Standards|Molport,Chemical Vendors,""
145711246,(E)-N-(3-Chloro-4-fluorophenyl)-4-(dimethylamino)-N-(6-((E)-4-(dimethylamino)but-2-enamido)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-yl)but-2-enamide (Afatinib Impurity pound(c),CS-0164236|(E)-N-(3-Chloro-4-fluorophenyl)-4-(dimethylamino)-N-(6-((E)-4-(dimethylamino)but-2-enamido)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-yl)but-2-enamide (Afatinib Impurity pound(c)|N-(3-Chloro-4-fluorophenyl)-4-(dimethylamino)-N-(6-(4-(dimethylamino)but-2-enamido)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-yl)but-2-enamide,597.100,C30H34ClFN6O4,100.000,955.000,3.300,42,1,9,11,"InChI=1S/C30H34ClFN6O4/c1-36(2)12-5-7-28(39)35-26-16-22-25(17-27(26)42-21-11-14-41-18-21)33-19-34-30(22)38(29(40)8-6-13-37(3)4)20-9-10-24(32)23(31)15-20/h5-10,15-17,19,21H,11-14,18H2,1-4H3,(H,35,39)/b7-5+,8-6+/t21-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)N(C3=CC(=C(C=C3)F)Cl)C(=O)/C=C/CN(C)C)O[C@H]4CCOC4,AAXMNDWXOYUWBM-FQQXRIEFSA-N,(E)-N-[4-(3-chloro-N-[(E)-4-(dimethylamino)but-2-enoyl]-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,596.2314094,596.2314094,0,1,0,1,1,0,2,2,0,0,0,0,"",Classification,1,"",20191231,AbaChemScene|BLD Pharm,Chemical Vendors,""
145711658,(Z)-4-((4-((4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-1-(dimethylamino)-4-oxobutan-2-yl)oxy)-4-oxobut-2-enoic Acid (Afatinib Impurity pound(c),CS-0164235|(Z)-4-((4-((4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-1-(dimethylamino)-4-oxobutan-2-yl)oxy)-4-oxobut-2-enoic acid|(Z)-4-((4-((4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-1-(dimethylamino)-4-oxobutan-2-yl)oxy)-4-oxobut-2-enoic Acid (Afatinib Impurity pound(c),602.000,C28H29ClFN5O7,152.000,962.000,0.800,42,3,12,13,"InChI=1S/C28H29ClFN5O7/c1-35(2)13-18(42-27(39)6-5-26(37)38)10-25(36)34-23-11-19-22(12-24(23)41-17-7-8-40-14-17)31-15-32-28(19)33-16-3-4-21(30)20(29)9-16/h3-6,9,11-12,15,17-18H,7-8,10,13-14H2,1-2H3,(H,34,36)(H,37,38)(H,31,32,33)/b6-5-/t17-,18?/m0/s1",CN(C)CC(CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)OC(=O)/C=C\C(=O)O,MAGMEMHASFDBDV-BHIBVNTLSA-N,(Z)-4-[4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-1-(dimethylamino)-4-oxobutan-2-yl]oxy-4-oxobut-2-enoic acid,601.1739541,601.1739541,0,1,0,2,1,1,1,1,0,0,0,0,"",Classification,1,"",20191231,AbaChemScene|BLD Pharm,Chemical Vendors,""
163323848,"(S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,8-diamine (Afatinib Impurity)","CS-0255331|(S)-N4-(3-Chloro-4-fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,8-diamine (Afatinib Impurity)",374.800,C18H16ClFN4O2,82.300,476.000,3.500,26,2,7,4,"InChI=1S/C18H16ClFN4O2/c19-13-7-10(1-3-14(13)20)24-18-12-2-4-15(26-11-5-6-25-8-11)16(21)17(12)22-9-23-18/h1-4,7,9,11H,5-6,8,21H2,(H,22,23,24)/t11-/m0/s1",C1COC[C@H]1OC2=C(C3=C(C=C2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl)N,XHOQLKYZPSIEKB-NSHDSACASA-N,"4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,8-diamine",374.0945816,374.0945816,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220607,AbaChemScene,Chemical Vendors,""
163197467,7-fluoro-6-nitro-4-[(3S)-oxolan-3-yl]oxyquinazoline,CS-0164274|(S)-7-fluoro-6-nitro-4-((tetrahydrofuran-3-yl)oxy)quinazoline? (Afatinib Impurity pound(c),279.220,C12H10FN3O4,90.100,367.000,1.800,20,0,7,2,"InChI=1S/C12H10FN3O4/c13-9-4-10-8(3-11(9)16(17)18)12(15-6-14-10)20-7-1-2-19-5-7/h3-4,6-7H,1-2,5H2/t7-/m0/s1",C1COC[C@H]1OC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F,YXCUFXWLKHQPRJ-ZETCQYMHSA-N,7-fluoro-6-nitro-4-[(3S)-oxolan-3-yl]oxyquinazoline,279.06553397,279.06553397,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197470,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-propan-2-yloxybut-2-enamide,"CS-0164279|(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-isopropoxybut-2-enamide? (Afatinib Impurity pound(c)",500.900,C25H26ClFN4O4,94.600,717.000,4.200,35,2,8,9,"InChI=1S/C25H26ClFN4O4/c1-15(2)34-8-3-4-24(32)31-22-11-18-21(12-23(22)35-17-7-9-33-13-17)28-14-29-25(18)30-16-5-6-20(27)19(26)10-16/h3-6,10-12,14-15,17H,7-9,13H2,1-2H3,(H,31,32)(H,28,29,30)/b4-3+/t17-/m0/s1",CC(C)OC/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,HYEVSBFMAWTGND-IDOMTICXSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-propan-2-yloxybut-2-enamide,500.1626612,500.1626612,0,1,0,1,1,0,1,1,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
155291479,N-(3-Chloro-4-fluorophenyl)-7-fluoro-8-nitroquinazolin-4-amine,N-(3-Chloro-4-fluorophenyl)-7-fluoro-8-nitroquinazolin-4-amine|CS-0164300|N-(3-chloro-4-fluorophenyl)-7-fluoro-8-nitroquinazolin-4-amine? (Afatinib Impurity pound(c),336.680,C14H7ClF2N4O2,83.600,441.000,4.100,23,1,7,2,"InChI=1S/C14H7ClF2N4O2/c15-9-5-7(1-3-10(9)16)20-14-8-2-4-11(17)13(21(22)23)12(8)18-6-19-14/h1-6H,(H,18,19,20)",C1=CC(=C(C=C1NC2=NC=NC3=C2C=CC(=C3[N+](=O)[O-])F)Cl)F,XFNAFXIABOVZSE-UHFFFAOYSA-N,N-(3-chloro-4-fluorophenyl)-7-fluoro-8-nitroquinazolin-4-amine,336.0225595,336.0225595,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20210106,AbaChemScene|BLD Pharm|Starshine Chemical,Chemical Vendors,""
62343287,4-Isopropoxybut-2-enoic acid,773866-66-3|4-Isopropoxybut-2-enoic acid|SCHEMBL18111984|4-(propan-2-yloxy)but-2-enoic acid|CS-0164271|EN300-1849666|(E)-4-isopropoxybut-2-enoic acid? (Afatinib Impurity pound(c),144.170,C7H12O3,46.500,127.000,0.700,10,1,3,4,"InChI=1S/C7H12O3/c1-6(2)10-5-3-4-7(8)9/h3-4,6H,5H2,1-2H3,(H,8,9)/b4-3+",CC(C)OC/C=C/C(=O)O,ODWQZOUHOJDDEW-ONEGZZNKSA-N,(E)-4-propan-2-yloxybut-2-enoic acid,144.078644241,144.078644241,0,1,0,0,0,0,1,1,0,0,19,2,"",Patents,1,"",20121022,"AbaChemScene|Ambinter|BLD Pharm|Enamine|Google Patents|PATENTSCOPE (WIPO)|Rare Chemicals GmbH, Germany|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
163197463,"N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide","2223677-65-2|N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide|CS-0164259|N1,N2-Bis(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide (Afatinib Impurity pound(c)",803.600,C38H30Cl2F2N8O6,171.000,1240.000,6.900,56,4,14,10,"InChI=1S/C38H30Cl2F2N8O6/c39-25-9-19(1-3-27(25)41)47-35-23-11-31(33(13-29(23)43-17-45-35)55-21-5-7-53-15-21)49-37(51)38(52)50-32-12-24-30(14-34(32)56-22-6-8-54-16-22)44-18-46-36(24)48-20-2-4-28(42)26(40)10-20/h1-4,9-14,17-18,21-22H,5-8,15-16H2,(H,49,51)(H,50,52)(H,43,45,47)(H,44,46,48)/t21-,22-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC(=O)C(=O)NC5=C(C=C6C(=C5)C(=NC=N6)NC7=CC(=C(C=C7)F)Cl)O[C@H]8CCOC8,NMHSIKFQDIYZSG-VXKWHMMOSA-N,"N,N'-bis[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]oxamide",802.1633424,802.1633424,0,1,0,2,2,0,0,0,0,0,0,0,"",Classification,1,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm",Chemical Vendors,""
163197477,3-(3-chloro-N-[6-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-7-(oxolan-3-yloxy)quinazolin-4-yl]-4-fluoroanilino)-N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)butanamide,CS-0164295|(E)-N-(4-((3-chloro-4-fluorophenyl)(4-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-1-(dimethylamino)-4-oxobutan-2-yl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide? (Afatinib,971.900,C48H50Cl2F2N10O6,168.000,1650.000,6.900,68,3,16,18,"InChI=1S/C48H50Cl2F2N10O6/c1-60(2)13-5-6-45(63)58-42-20-34-40(22-44(42)68-32-12-15-66-25-32)54-27-56-48(34)62(29-8-10-38(52)36(50)17-29)30(23-61(3)4)18-46(64)59-41-19-33-39(21-43(41)67-31-11-14-65-24-31)53-26-55-47(33)57-28-7-9-37(51)35(49)16-28/h5-10,16-17,19-22,26-27,30-32H,11-15,18,23-25H2,1-4H3,(H,58,63)(H,59,64)(H,53,55,57)/b6-5+",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)N(C3=CC(=C(C=C3)F)Cl)C(CC(=O)NC4=C(C=C5C(=C4)C(=NC=N5)NC6=CC(=C(C=C6)F)Cl)OC7CCOC7)CN(C)C)OC8CCOC8,GRHQVOFTIOOKMN-AATRIKPKSA-N,3-(3-chloro-N-[6-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-7-(oxolan-3-yloxy)quinazolin-4-yl]-4-fluoroanilino)-N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)butanamide,970.3259911,970.3259911,0,1,0,3,0,3,1,1,0,0,0,0,"",Classification,1,"",20220430,"AbaChemScene|Pharmacore Co., Limited",Chemical Vendors,""
163197481,"N-(3-chloro-4-fluorophenyl)-7-fluoro-6,8-dinitroquinazolin-4-amine","CS-0164301|N-(3-chloro-4-fluorophenyl)-7-fluoro-6,8-dinitroquinazolin-4-amine? (Afatinib Impurity pound(c)",381.680,C14H6ClF2N5O4,129.000,550.000,3.900,26,1,9,2,"InChI=1S/C14H6ClF2N5O4/c15-8-3-6(1-2-9(8)16)20-14-7-4-10(21(23)24)11(17)13(22(25)26)12(7)18-5-19-14/h1-5H,(H,18,19,20)",C1=CC(=C(C=C1NC2=NC=NC3=C(C(=C(C=C32)[N+](=O)[O-])F)[N+](=O)[O-])Cl)F,UPNBZMUYFAYTHE-UHFFFAOYSA-N,"N-(3-chloro-4-fluorophenyl)-7-fluoro-6,8-dinitroquinazolin-4-amine",381.0076377,381.0076377,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
71330663,3-Methylquinoline-5-sulfonyl chloride,"3-Methylquinoline-5-sulfonyl chloride|94975-84-5|5-Quinolinesulfonyl chloride, 3-methyl-|DTXSID90759333|CS-0163959|3-Methylquinoline-5-sulfonyl chloride (Afatinib Impurity pound(c)",241.690,C10H8ClNO2S,55.400,325.000,2.600,15,0,3,1,"InChI=1S/C10H8ClNO2S/c1-7-5-8-9(12-6-7)3-2-4-10(8)15(11,13)14/h2-6H,1H3",CC1=CC2=C(C=CC=C2S(=O)(=O)Cl)N=C1,HTAMTFRQJZCNAH-UHFFFAOYSA-N,3-methylquinoline-5-sulfonyl chloride,240.9964274,240.9964274,0,1,0,0,0,0,0,0,0,0,1,1,"",Patents,1,"",20130521,"A2B Chem|AA BLOCKS|AbaChemScene|Achemica|AiFChem, an XtalPi Company|BenchChem|BLD Pharm|BOC Sciences|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemTik|Cooke Chemical Co., Ltd|CymitQuimica|EPA DSSTox|EvitaChem|Google Patents|J&H Chemical Co.,ltd|PATENTSCOPE (WIPO)|RR Scientific|Starshine Chemical|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
124118390,"(E)-N,N-Dimethyl-4-(methylamino)but-2-enamide","(E)-N,N-Dimethyl-4-(methylamino)but-2-enamide|2348580-72-1|SCHEMBL18293708|CS-0164234|(E)-N,N-Dimethyl-4-(methylamino)but-2-enamide (Afatinib Impurity)",142.200,C7H14N2O,32.299,130.000,-0.400,10,1,2,3,"InChI=1S/C7H14N2O/c1-8-6-4-5-7(10)9(2)3/h4-5,8H,6H2,1-3H3/b5-4+",CNC/C=C/C(=O)N(C)C,RKSIKZIMBXUQRN-SNAWJCMRSA-N,"(E)-N,N-dimethyl-4-(methylamino)but-2-enamide",142.110613074,142.110613074,0,1,0,0,0,0,1,1,0,0,9,5,"",Patents,1,"",20170218,A2B Chem|AbaChemScene|AKos Consulting & Solutions|BOC Sciences|Google Patents|LGC Standards|Life Chemicals|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
154631204,7-[(3S)-oxolan-3-yl]oxy-4-propan-2-yloxyquinazolin-6-amine,CS-0164290|(S)-4-isopropoxy-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-amine? (Afatinib Impurity pound(c),289.330,C15H19N3O3,79.500,342.000,2.000,21,1,6,4,"InChI=1S/C15H19N3O3/c1-9(2)20-15-11-5-12(16)14(6-13(11)17-8-18-15)21-10-3-4-19-7-10/h5-6,8-10H,3-4,7,16H2,1-2H3/t10-/m0/s1",CC(C)OC1=NC=NC2=CC(=C(C=C21)N)O[C@H]3CCOC3,IPGRRUQIURPTLV-JTQLQIEISA-N,7-[(3S)-oxolan-3-yl]oxy-4-propan-2-yloxyquinazolin-6-amine,289.14264148,289.14264148,0,1,0,1,1,0,0,0,0,0,0,0,"",Patents,1,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
163197465,N-(4-chloro-3-fluorophenyl)-6-fluoro-7-nitronaphthalen-1-amine,CS-0164270|N-(4-chloro-3-fluorophenyl)-6-fluoro-7-nitronaphthalen-1-amine? (Afatinib Impurity pound(c),334.700,C16H9ClF2N2O2,57.900,437.000,5.400,23,1,5,2,"InChI=1S/C16H9ClF2N2O2/c17-12-5-4-10(7-13(12)18)20-15-3-1-2-9-6-14(19)16(21(22)23)8-11(9)15/h1-8,20H",C1=CC2=CC(=C(C=C2C(=C1)NC3=CC(=C(C=C3)Cl)F)[N+](=O)[O-])F,WFMLLXQJDJFHFC-UHFFFAOYSA-N,N-(4-chloro-3-fluorophenyl)-6-fluoro-7-nitronaphthalen-1-amine,334.0320616,334.0320616,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197475,"N-(3,4-difluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine","CS-0164293|(S)-N-(3,4-difluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine? (Afatinib Impurity pound(c)",388.300,C18H14F2N4O4,102.000,554.000,3.500,28,1,9,4,"InChI=1S/C18H14F2N4O4/c19-13-2-1-10(5-14(13)20)23-18-12-6-16(24(25)26)17(7-15(12)21-9-22-18)28-11-3-4-27-8-11/h1-2,5-7,9,11H,3-4,8H2,(H,21,22,23)/t11-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)F)[N+](=O)[O-],KIZUOSHIXNCSDB-NSHDSACASA-N,"N-(3,4-difluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine",388.09831126,388.09831126,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197476,N-(3-chloro-2-fluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,CS-0164294|(S)-N-(3-chloro-2-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine? (Afatinib Impurity pound(c),404.800,C18H14ClFN4O4,102.000,556.000,4.000,28,1,8,4,"InChI=1S/C18H14ClFN4O4/c19-12-2-1-3-13(17(12)20)23-18-11-6-15(24(25)26)16(7-14(11)21-9-22-18)28-10-4-5-27-8-10/h1-3,6-7,9-10H,4-5,8H2,(H,21,22,23)/t10-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=C(C(=CC=C4)Cl)F)[N+](=O)[O-],KNDKOSOZDFPVKF-JTQLQIEISA-N,N-(3-chloro-2-fluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,404.0687608,404.0687608,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197483,N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]hydroxylamine,CS-0164303|(S)-N-(3-chloro-4-fluorophenyl)-6-(hydroxyamino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine? (Afatinib Impurity pound(c),390.800,C18H16ClFN4O3,88.500,494.000,3.700,27,3,8,5,"InChI=1S/C18H16ClFN4O3/c19-13-5-10(1-2-14(13)20)23-18-12-6-16(24-25)17(7-15(12)21-9-22-18)27-11-3-4-26-8-11/h1-2,5-7,9,11,24-25H,3-4,8H2,(H,21,22,23)/t11-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NO,YHMWAGBHLKHWEV-NSHDSACASA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]hydroxylamine,390.0894962,390.0894962,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197484,N-(3-chloro-4-fluorophenyl)-6-nitroso-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,CS-0164304|(S)-N-(3-chloro-4-fluorophenyl)-6-nitroso-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine? (Afatinib Impurity pound(c),388.800,C18H14ClFN4O3,85.700,519.000,3.500,27,1,8,4,"InChI=1S/C18H14ClFN4O3/c19-13-5-10(1-2-14(13)20)23-18-12-6-16(24-25)17(7-15(12)21-9-22-18)27-11-3-4-26-8-11/h1-2,5-7,9,11H,3-4,8H2,(H,21,22,23)/t11-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N=O,PASRTHTVCNVAEQ-NSHDSACASA-N,N-(3-chloro-4-fluorophenyl)-6-nitroso-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,388.0738462,388.0738462,0,1,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197485,"6,6'-((E)-Diazene-1,2-diyl)bis(N-(3-chloro-4-fluorophenyl)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine)","CS-0164305|(S)-6,6'-((E)-diazene-1,2-diyl)bis(N-(3-chloro-4-fluorophenyl)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine)? (Afatinib Impurity pound(c)|6,6'-((E)-Diazene-1,2-diyl)bis(N-(3-chloro-4-fluorophenyl)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine)",745.600,C36H28Cl2F2N8O4,137.000,1110.000,8.200,52,2,14,10,"InChI=1S/C36H28Cl2F2N8O4/c37-25-9-19(1-3-27(25)39)45-35-23-11-31(33(13-29(23)41-17-43-35)51-21-5-7-49-15-21)47-48-32-12-24-30(14-34(32)52-22-6-8-50-16-22)42-18-44-36(24)46-20-2-4-28(40)26(38)10-20/h1-4,9-14,17-18,21-22H,5-8,15-16H2,(H,41,43,45)(H,42,44,46)/t21-,22-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N=NC5=C(C=C6C(=C5)C(=NC=N6)NC7=CC(=C(C=C7)F)Cl)O[C@H]8CCOC8,BIXUYYOJSKZUPJ-VXKWHMMOSA-N,6-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]diazenyl]-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,744.1578631,744.1578631,0,1,0,2,2,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene|BLD Pharm,Chemical Vendors,""
135589780,7-Hydroxy-6-nitro-3H-quinazolin-4-one,"6-Nitroquinazoline-4,7-diol|7-Hydroxy-6-nitro-3H-quinazolin-4-one|574738-64-0|SCHEMBL4371995|DGAQZMKEHDOLCK-UHFFFAOYSA-N|6-nitro-7-hydroxyquinazolin-4-one|CS-0200328|6-Nitroquinazoline-4,7-diol (Afatinib Impurity)",207.140,C8H5N3O4,108.000,324.000,0.700,15,2,5,0,"InChI=1S/C8H5N3O4/c12-7-2-5-4(1-6(7)11(14)15)8(13)10-3-9-5/h1-3,12H,(H,9,10,13)",C1=C2C(=CC(=C1[N+](=O)[O-])O)N=CNC2=O,DGAQZMKEHDOLCK-UHFFFAOYSA-N,7-hydroxy-6-nitro-3H-quinazolin-4-one,207.02800565,207.02800565,0,1,0,0,0,0,0,0,0,0,8,1,"",Patents,1,"",20190115,"10X CHEM|A2B Chem|AbaChemScene|AiFChem, an XtalPi Company|AppChem|BLD Pharm|ChemSpider|Combi-Blocks|Google Patents|IBM|Mcule|Molport|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
55299487,(E)-Ethyl 4-(Methylamino)but-2-enoate,1259015-90-1|(E)-Ethyl 4-(Methylamino)but-2-enoate|ethyl (2E)-4-(methylamino)but-2-enoate|SCHEMBL11805646|AKOS006377814|Ethyl (E)-4-(methylamino)but-2-enoate|CS-0164233|EN300-21926651|(2E)-4-(Methylamino)-2-butenoic Acid Ethyl Ester (Afatinib Impurity),143.180,C7H13NO2,38.300,121.000,0.300,10,1,3,5,"InChI=1S/C7H13NO2/c1-3-10-7(9)5-4-6-8-2/h4-5,8H,3,6H2,1-2H3/b5-4+",CCOC(=O)/C=C/CNC,WUOJOCFGEVRKJF-SNAWJCMRSA-N,ethyl (E)-4-(methylamino)but-2-enoate,143.094628657,143.094628657,0,1,0,0,0,0,1,1,0,0,1,1,"",Patents,1,"",20120124,10X CHEM|A2B Chem|AbaChemScene|AKos Consulting & Solutions|AppChem|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|BOC Sciences|CymitQuimica|Enamine|EvitaChem|LGC Standards|Molport|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
55299727,methyl (2E)-4-(methylamino)but-2-enoate,915788-22-6|methyl (2E)-4-(methylamino)but-2-enoate|SCHEMBL4963599|SCHEMBL4963608|AKOS006378505|methyl (E)-4-(methylamino)but-2-enoate|CS-0163963|EN300-7606555|(2E)-4-(Methylamino)-2-butenoic Acid Methyl Ester (Afatinib Impurity pound(c),129.160,C6H11NO2,38.300,110.000,-0.100,9,1,3,4,"InChI=1S/C6H11NO2/c1-7-5-3-4-6(8)9-2/h3-4,7H,5H2,1-2H3/b4-3+",CNC/C=C/C(=O)OC,PMVWCQUEDYFAPT-ONEGZZNKSA-N,methyl (E)-4-(methylamino)but-2-enoate,129.078978594,129.078978594,0,1,0,0,0,0,1,1,0,0,41,13,"",Patents,1,"",20120124,A2B Chem|AbaChemScene|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BLD Pharm|CymitQuimica|Enamine|Google Patents|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
154631197,6-nitro-7-[(3S)-oxolan-3-yl]oxy-4-propan-2-yloxyquinazoline,CS-0164278|(S)-4-isopropoxy-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazoline? (Afatinib Impurity pound(c),319.310,C15H17N3O5,99.300,416.000,2.500,23,0,7,4,"InChI=1S/C15H17N3O5/c1-9(2)22-15-11-5-13(18(19)20)14(6-12(11)16-8-17-15)23-10-3-4-21-7-10/h5-6,8-10H,3-4,7H2,1-2H3/t10-/m0/s1",CC(C)OC1=NC=NC2=CC(=C(C=C21)[N+](=O)[O-])O[C@H]3CCOC3,YTZJZLAARVRUAS-JTQLQIEISA-N,6-nitro-7-[(3S)-oxolan-3-yl]oxy-4-propan-2-yloxyquinazoline,319.11682065,319.11682065,0,1,0,1,1,0,0,0,0,0,0,0,"",Patents,1,"",20200928,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
163197471,"1-N,6-N-bis(3-chloro-4-fluorophenyl)isoquinoline-1,6,7-triamine","CS-0164282|N1,N6-bis(3-chloro-4-fluorophenyl)isoquinoline-1,6,7-triamine? (Afatinib Impurity pound(c)",431.300,C21H14Cl2F2N4,63.000,545.000,6.300,29,3,6,4,"InChI=1S/C21H14Cl2F2N4/c22-15-8-12(1-3-17(15)24)28-20-7-11-5-6-27-21(14(11)10-19(20)26)29-13-2-4-18(25)16(23)9-13/h1-10,28H,26H2,(H,27,29)",C1=CC(=C(C=C1NC2=C(C=C3C(=C2)C=CN=C3NC4=CC(=C(C=C4)F)Cl)N)Cl)F,FNRUSPYNAIYBQL-UHFFFAOYSA-N,"1-N,6-N-bis(3-chloro-4-fluorophenyl)isoquinoline-1,6,7-triamine",430.0563582,430.0563582,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197487,[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]imino-oxidoazanium,"CS-0164307|(Z)-1,2-bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)diazene oxide? (Afatinib Impurity pound(c)",761.600,C36H28Cl2F2N8O5,154.000,1240.000,7.600,53,2,14,10,"InChI=1S/C36H28Cl2F2N8O5/c37-25-9-19(1-3-27(25)39)45-35-23-11-31(33(13-29(23)41-17-43-35)52-21-5-7-50-15-21)47-48(49)32-12-24-30(14-34(32)53-22-6-8-51-16-22)42-18-44-36(24)46-20-2-4-28(40)26(38)10-20/h1-4,9-14,17-18,21-22H,5-8,15-16H2,(H,41,43,45)(H,42,44,46)/t21-,22-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N=[N+](C5=C(C=C6C(=C5)C(=NC=N6)NC7=CC(=C(C=C7)F)Cl)O[C@H]8CCOC8)[O-],VTTDQWWKXDOEAW-VXKWHMMOSA-N,[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]imino-oxidoazanium,760.1527777,760.1527777,0,1,0,2,2,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197488,2-Amino-4-fluoro-3-nitrobenzoic acid,CS-0164314|2-amino-4-fluoro-3-nitrobenzoic acid? (Afatinib Impurity pound(c),200.120,C7H5FN2O4,109.000,255.000,1.200,14,2,6,1,"InChI=1S/C7H5FN2O4/c8-4-2-1-3(7(11)12)5(9)6(4)10(13)14/h1-2H,9H2,(H,11,12)",C1=CC(=C(C(=C1C(=O)O)N)[N+](=O)[O-])F,ICUULOXDQBIDHU-UHFFFAOYSA-N,2-amino-4-fluoro-3-nitrobenzoic acid,200.02333481,200.02333481,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
15104040,"(E)-4-bromo-N,N-dimethylbut-2-enamide","(E)-4-bromo-N,N-dimethylbut-2-enamide|137131-09-0|4-Bromo-N,N-dimethylbut-2-enamide|2307859-60-3|(2E)-4-bromo-N,N-dimethylbut-2-enamide|SCHEMBL16336247|SCHEMBL16336249|OFBHRFQOAARPHM-ONEGZZNKSA-N|AKOS028113374|CS-0164311|(E)-4-bromo-N,N-dimethylbut-2-enamide? (Afatinib Impurity pound(c)",192.050,C6H10BrNO,20.300,120.000,0.700,9,0,1,2,"InChI=1S/C6H10BrNO/c1-8(2)6(9)4-3-5-7/h3-4H,5H2,1-2H3/b4-3+",CN(C)C(=O)/C=C/CBr,OFBHRFQOAARPHM-ONEGZZNKSA-N,"(E)-4-bromo-N,N-dimethylbut-2-enamide",190.99458,190.99458,0,1,0,0,0,0,1,1,0,0,102,19,"",Patents,1,"",20070209,"001Chemical|AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Ambinter|BenchChem|BLD Pharm|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|CymitQuimica|EvitaChem|Google Patents|NextMove Software|PATENTSCOPE (WIPO)|Sinfoo Biotech|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Wubei-Biochem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
88929802,"(E)-4-(Dimethylamino)-N,N-dimethylbut-2-enamide","(E)-4-(Dimethylamino)-N,N-dimethylbut-2-enamide|2636135-41-4|SCHEMBL12519507|CS-0164232|(E)-4-(Dimethylamino)-N,N-dimethylbut-2-enamide (Afatinib Impurity)",156.230,C8H16N2O,23.600,150.000,0.000,11,0,2,3,"InChI=1S/C8H16N2O/c1-9(2)7-5-6-8(11)10(3)4/h5-6H,7H2,1-4H3/b6-5+",CN(C)C/C=C/C(=O)N(C)C,WNAOQBGAGBIGLT-AATRIKPKSA-N,"(E)-4-(dimethylamino)-N,N-dimethylbut-2-enamide",156.126263138,156.126263138,0,1,0,0,0,0,1,1,0,0,9,9,"",Patents,1,"",20150213,"AbaChemScene|AiFChem, an XtalPi Company|Ambinter|BLD Pharm|PATENTSCOPE (WIPO)|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
163197466,"1-N,6-N-bis(3-chloro-4-fluorophenyl)-7-nitroisoquinoline-1,6-diamine","CS-0164272|N1,N6-bis(3-chloro-4-fluorophenyl)-7-nitroisoquinoline-1,6-diamine? (Afatinib Impurity pound(c)",461.200,C21H12Cl2F2N4O2,82.800,631.000,7.400,31,2,7,4,"InChI=1S/C21H12Cl2F2N4O2/c22-15-8-12(1-3-17(15)24)27-19-7-11-5-6-26-21(14(11)10-20(19)29(30)31)28-13-2-4-18(25)16(23)9-13/h1-10,27H,(H,26,28)",C1=CC(=C(C=C1NC2=C(C=C3C(=C2)C=CN=C3NC4=CC(=C(C=C4)F)Cl)[N+](=O)[O-])Cl)F,MJQXWPYGTXWQAG-UHFFFAOYSA-N,"1-N,6-N-bis(3-chloro-4-fluorophenyl)-7-nitroisoquinoline-1,6-diamine",460.0305374,460.0305374,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197478,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-hydroxybut-2-enamide,CS-0164296|(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-hydroxybut-2-enamide? (Afatinib Impurity pound(c),458.900,C22H20ClFN4O4,106.000,659.000,2.900,32,3,8,7,"InChI=1S/C22H20ClFN4O4/c23-16-8-13(3-4-17(16)24)27-22-15-9-19(28-21(30)2-1-6-29)20(10-18(15)25-12-26-22)32-14-5-7-31-11-14/h1-4,8-10,12,14,29H,5-7,11H2,(H,28,30)(H,25,26,27)/b2-1+",C1COCC1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC(=O)/C=C/CO,XZMUSENASPIMAT-OWOJBTEDSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-hydroxybut-2-enamide,458.1157110,458.1157110,0,1,0,1,0,1,1,1,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197480,N-(3-chloro-4-fluorophenyl)-7-fluoroquinazolin-4-amine,CS-0164299|N-(3-chloro-4-fluorophenyl)-7-fluoroquinazolin-4-amine? (Afatinib Impurity pound(c),291.680,C14H8ClF2N3,37.800,334.000,4.200,20,1,5,2,"InChI=1S/C14H8ClF2N3/c15-11-6-9(2-4-12(11)17)20-14-10-3-1-8(16)5-13(10)18-7-19-14/h1-7H,(H,18,19,20)",C1=CC(=C(C=C1NC2=NC=NC3=C2C=CC(=C3)F)Cl)F,WYYDIASYJLKNKP-UHFFFAOYSA-N,N-(3-chloro-4-fluorophenyl)-7-fluoroquinazolin-4-amine,291.0374813,291.0374813,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
163197482,"7-fluoro-6,8-dinitro-3H-quinazolin-4-one","CS-0164302|7-fluoro-6,8-dinitroquinazolin-4-ol? (Afatinib Impurity pound(c)",254.130,C8H3FN4O5,133.000,430.000,0.500,18,1,7,0,"InChI=1S/C8H3FN4O5/c9-5-4(12(15)16)1-3-6(7(5)13(17)18)10-2-11-8(3)14/h1-2H,(H,10,11,14)",C1=C2C(=C(C(=C1[N+](=O)[O-])F)[N+](=O)[O-])N=CNC2=O,PLAHCTNYJROQSY-UHFFFAOYSA-N,"7-fluoro-6,8-dinitro-3H-quinazolin-4-one",254.00874737,254.00874737,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220430,"AbaChemScene|Pharmacore Co., Limited",Chemical Vendors,""
163197486,6-[2-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]hydrazinyl]-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,"CS-0164306|(S)-6,6'-(hydrazine-1,2-diyl)bis(N-(3-chloro-4-fluorophenyl)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine)? (Afatinib Impurity pound(c)",747.600,C36H30Cl2F2N8O4,137.000,1060.000,8.300,52,4,14,11,"InChI=1S/C36H30Cl2F2N8O4/c37-25-9-19(1-3-27(25)39)45-35-23-11-31(33(13-29(23)41-17-43-35)51-21-5-7-49-15-21)47-48-32-12-24-30(14-34(32)52-22-6-8-50-16-22)42-18-44-36(24)46-20-2-4-28(40)26(38)10-20/h1-4,9-14,17-18,21-22,47-48H,5-8,15-16H2,(H,41,43,45)(H,42,44,46)/t21-,22-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NNC5=C(C=C6C(=C5)C(=NC=N6)NC7=CC(=C(C=C7)F)Cl)O[C@H]8CCOC8,GFFMDQWKLRGXEW-VXKWHMMOSA-N,6-[2-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]hydrazinyl]-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,746.1735132,746.1735132,0,1,0,2,2,0,0,0,0,0,0,0,"",Classification,1,"",20220430,AbaChemScene,Chemical Vendors,""
162641266,(2Z)-Afatinib-d6,"(2Z)-Afatinib-d6|Afatinib-d6 Dimaleate (N,N-dimethyl-d6)|HY-142384S|CS-0371949",492.000,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3-/t16-/m0/s1/i1D3,2D3",[2H]C([2H])([2H])N(C/C=C\C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)C([2H])([2H])[2H],ULXXDDBFHOBEHA-WWAULGHUSA-N,(Z)-4-[bis(trideuteriomethyl)amino]-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide,491.2006560,491.2006560,0,1,6,1,1,0,1,1,0,0,0,0,"","",0,"",20220315,AbaChemScene|LGC Standards|MedChemexpress MCE,Chemical Vendors,""
121494036,Afatinib-d6 (dimaleate),Afatinib-d6 (dimaleate)|AFATINIB-D6 DIMALEATE|HY-10261AS|CS-0227374|F90442,724.100,C32H33ClFN5O11,238.000,820.000,"",50,6,16,12,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1/i1D3,2D3;;",[2H]C(N(C([2H])([2H])[2H])C/C=C/C(=O)NC1=C(C=C2N=CN=C(C2=C1)NC3=CC(=C(C=C3)F)Cl)O[C@@H]4COCC4)([2H])[2H].C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O,USNRYVNRPYXCSP-PELYZBGRSA-N,(E)-4-[bis(trideuteriomethyl)amino]-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide;(Z)-but-2-enedioic acid,723.2225732,723.2225732,0,3,6,1,1,0,3,3,0,0,0,0,"","",0,"",20160827,"AbaChemScene|AstaTech, Inc.|Clearsynth|MedChemexpress MCE",Chemical Vendors,""
73416312,"(2R,4R)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)","CS-0164256|(2R,4R)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2- [[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)",508.600,C23H36N6O5S,189.000,887.000,1.300,35,5,8,9,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15+,17-,18-/m1/s1",C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@H](C3)C,KXNPVXPOPUZYGB-CYGHRXIMSA-N,"(2R,4R)-1-[(2R)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",508.24678944,508.24678944,0,1,0,4,4,0,0,0,0,0,0,0,"","",0,"",20140409,AbaChemScene|ZINC,Chemical Vendors|Legacy Depositors,""
124386005,"(2S,4S)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)","CS-0164257|(2S,4S)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2- [[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)",508.600,C23H36N6O5S,189.000,887.000,1.300,35,5,8,9,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15-,17+,18-/m0/s1",C[C@H]1CCN([C@@H](C1)C(=O)O)C(=O)[C@@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@H](C3)C,KXNPVXPOPUZYGB-ONIAQPFYSA-N,"(2S,4S)-1-[(2R)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",508.24678944,508.24678944,0,1,0,4,4,0,0,0,0,0,0,0,"","",0,"",20170410,AbaChemScene|ZINC,Chemical Vendors|Legacy Depositors,""
124564299,"(2S,4R)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)","CS-0164255|(2S,4R)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2- [[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)",508.600,C23H36N6O5S,189.000,887.000,1.300,35,5,8,9,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15+,17-,18+/m1/s1",C[C@@H]1CCN([C@@H](C1)C(=O)O)C(=O)[C@@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@H](C3)C,KXNPVXPOPUZYGB-ATLSCFEFSA-N,"(2S,4R)-1-[(2R)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",508.24678944,508.24678944,0,1,0,4,4,0,0,0,0,0,0,0,"","",0,"",20170410,AbaChemScene|ZINC,Chemical Vendors|Legacy Depositors,""
168356125,2-Chloro-Afatinib,2-Chloro-Afatinib|YND67763,502.400,C24H25Cl2N5O3,88.600,700.000,4.200,34,2,7,8,"InChI=1S/C24H25Cl2N5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-18(25)19(26)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)",CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)Cl)OC4CCOC4,GMLBQFFEIVQHIS-UHFFFAOYSA-N,"N-[4-(3,4-dichloroanilino)-7-(oxolan-3-yloxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide",501.1334451,501.1334451,0,1,0,1,0,1,1,0,1,0,0,0,"","",0,"",20230711,"Biosynth|Cooke Chemical Co., Ltd|Mcule",Chemical Vendors,""
169432884,Afatinib-D6 dimaleate,AFATINIB-D6 DIMALEATE|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate-d6; BIBW 2992MA2-d6,608.000,C28H29ClFN5O7,163.000,820.000,"",42,4,12,10,"InChI=1S/C24H25ClFN5O3.C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);1-2H,(H,5,6)(H,7,8)/b4-3+;2-1-/t16-;/m0./s1/i1D3,2D3;",[2H]C([2H])([2H])N(C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)C([2H])([2H])[2H].C(=C\C(=O)O)\C(=O)O,LIENDGDDWJRJLO-JIUOTHPNSA-N,(E)-4-[bis(trideuteriomethyl)amino]-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide;(Z)-but-2-enedioic acid,607.2116146,607.2116146,0,2,6,1,1,0,2,2,0,0,0,0,"","",0,"",20231201,LGC Standards,Chemical Vendors,""
131632287,Afatinib; bis(butenedioic acid),AFATINIB; BIS(BUTENEDIOIC ACID),718.100,C32H33ClFN5O11,238.000,820.000,"",50,6,16,12,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/t16-;;/m0../s1",CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,USNRYVNRPYXCSP-SQKCAUCHSA-N,but-2-enedioic acid;N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,717.1849127,717.1849127,0,3,0,1,1,0,3,0,3,0,0,0,"","",0,"",20171013,King Scientific|Molecule Market,Chemical Vendors|Legacy Depositors,""
71313050,Afatinib-d4,Afatinib-d4|HY-10261S1|CS-0371274,490.000,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1/i9D2,13D2",[2H]C1(C[C@@H](C(O1)([2H])[2H])OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)NC(=O)/C=C/CN(C)C)[2H],ULXXDDBFHOBEHA-YVZQKSMPSA-N,"(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-2,2,5,5-tetradeuteriooxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide",489.1881025,489.1881025,0,1,4,1,1,0,1,1,0,0,0,0,"","",0,"",20130517,AbaChemScene|Chembase.cn|Clearsynth|Clinivex|LGC Standards|MedChemexpress MCE,Chemical Vendors|Legacy Depositors,""
49806202,Afatinib (oxalate),Afatinib (oxalate)|HY-10261D|CS-0179269,576.000,C26H27ClFN5O7,163.000,773.000,"",40,4,12,9,"InChI=1S/C24H25ClFN5O3.C2H2O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;3-1(4)2(5)6/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);(H,3,4)(H,5,6)/b4-3+;/t16-;/m0./s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4.C(=O)(C(=O)O)O,BBWOQZNSNOUXFP-KHNHNNODSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide;oxalic acid,575.1583041,575.1583041,0,2,0,1,1,0,1,1,0,0,0,0,"","",0,"",20101227,AbaChemScene|DiscoveryGate|MedChemexpress MCE|Thomson Pharma,Chemical Vendors|Journal Publishers|Legacy Depositors|Subscription Services,""
163197320,"(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)","CS-0163958|(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-2-[[(3- methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)",456.500,C23H32N6O4,156.000,700.000,-0.300,33,4,7,9,"InChI=1S/C23H32N6O4/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-33-19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,11,13-14,17-18,28H,4,6,8-10,12H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,17+,18-/m1/s1",C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NOC2=CC=CC3=C2N=CC(=C3)C,NTXOEINSKQDLKE-FHLIZLRMSA-N,"(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methylquinolin-8-yl)oxyamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",456.24850352,456.24850352,0,1,0,3,3,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
138108795,"7-Hydroxy-6,8-dinitroquinazolin-4(3H)-one","7-Hydroxy-6,8-dinitroquinazolin-4(3H)-one|2250242-14-7|Afatinib Impurity 1",252.140,C8H4N4O6,153.000,426.000,0.600,18,2,7,0,"InChI=1S/C8H4N4O6/c13-7-4(11(15)16)1-3-5(6(7)12(17)18)9-2-10-8(3)14/h1-2,13H,(H,9,10,14)",C1=C2C(=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])N=CNC2=O,SOTHRICPRUOGRW-UHFFFAOYSA-N,"7-hydroxy-6,8-dinitro-3H-quinazolin-4-one",252.01308386,252.01308386,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20190508,"AstaTech, Inc.|BLD Pharm|Molport|Starshine Chemical",Chemical Vendors,""
163197468,"6-nitro-4,7-bis[[(3S)-oxolan-3-yl]oxy]quinazoline","CS-0164276|6-nitro-4,7-bis(((S)-tetrahydrofuran-3-yl)oxy)quinazoline? (Afatinib Impurity pound(c)",347.320,C16H17N3O6,109.000,475.000,1.700,25,0,8,4,"InChI=1S/C16H17N3O6/c20-19(21)14-5-12-13(6-15(14)24-10-1-3-22-7-10)17-9-18-16(12)25-11-2-4-23-8-11/h5-6,9-11H,1-4,7-8H2/t10-,11-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3O[C@H]4CCOC4)[N+](=O)[O-],RTAVWJKQBSSNOF-QWRGUYRKSA-N,"6-nitro-4,7-bis[[(3S)-oxolan-3-yl]oxy]quinazoline",347.11173527,347.11173527,0,1,0,2,2,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197473,"4-N-[3-chloro-4-[(3S)-oxolan-3-yl]oxyphenyl]-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine","CS-0164289|N4-(3-chloro-4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine? (Afatinib Impurity pound(c)",442.900,C22H23ClN4O4,101.000,590.000,3.400,31,2,8,6,"InChI=1S/C22H23ClN4O4/c23-17-7-13(1-2-20(17)30-14-3-5-28-10-14)27-22-16-8-18(24)21(9-19(16)25-12-26-22)31-15-4-6-29-11-15/h1-2,7-9,12,14-15H,3-6,10-11,24H2,(H,25,26,27)/t14-,15-/m0/s1",C1COC[C@H]1OC2=C(C=C(C=C2)NC3=NC=NC4=CC(=C(C=C43)N)O[C@H]5CCOC5)Cl,VBPUISKZJYZGPH-GJZGRUSLSA-N,"4-N-[3-chloro-4-[(3S)-oxolan-3-yl]oxyphenyl]-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine",442.1407829,442.1407829,0,1,0,2,2,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
11381509,dimethyl (2S)-2-(4-methylphenyl)sulfonyloxybutanedioate,CS-0164318|(S)-dimethyl 2-(tosyloxy)succinate? (Afatinib Impurity pound(c),316.330,C13H16O7S,104.000,457.000,1.400,21,0,7,8,"InChI=1S/C13H16O7S/c1-9-4-6-10(7-5-9)21(16,17)20-11(13(15)19-3)8-12(14)18-2/h4-7,11H,8H2,1-3H3/t11-/m0/s1",CC1=CC=C(C=C1)S(=O)(=O)O[C@@H](CC(=O)OC)C(=O)OC,UWYSDPCSKWDRBU-NSHDSACASA-N,dimethyl (2S)-2-(4-methylphenyl)sulfonyloxybutanedioate,316.06167402,316.06167402,0,1,0,1,1,0,0,0,0,0,0,0,"","",0,"",20061026,AbaChemScene|ChemSpider|DiscoveryGate|NextBio|Thomson Pharma,Chemical Vendors|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
163197525,"(2R,4S)-4-Methyl-1-((((S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl)-L-arginyl)piperidine-2-carboxylic acid","(2R,4S)-4-Methyl-1-((((S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl)-L-arginyl)piperidine-2-carboxylic acid|446063-74-7|CS-0164391|(2R,4S)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2- [[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)",508.600,C23H36N6O5S,189.000,887.000,1.300,35,5,8,9,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15-,17-,18+/m0/s1",C[C@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@H](C3)C,KXNPVXPOPUZYGB-UOVPBQLFSA-N,"(2R,4S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",508.24678944,508.24678944,0,1,0,4,4,0,0,0,0,0,0,0,"","",0,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm",Chemical Vendors,""
124385077,"(2R,4S)-4-Methyl-1-((((S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl)-D-arginyl)piperidine-2-carboxylic acid","CS-0164254|(2R,4S)-1-[(2R)-5-[(Aminoiminomethyl)amino]-1-oxo-2- [[[(3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid (Afatinib Impurity pound(c)|(2R,4S)-4-Methyl-1-((((S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl)-D-arginyl)piperidine-2-carboxylic acid",508.600,C23H36N6O5S,189.000,887.000,1.300,35,5,8,9,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15-,17+,18+/m0/s1",C[C@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@H](C3)C,KXNPVXPOPUZYGB-CWLKWCNXSA-N,"(2R,4S)-1-[(2R)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",508.24678944,508.24678944,0,1,0,4,4,0,0,0,0,0,0,0,"","",0,"",20170410,AbaChemScene|BLD Pharm|ZINC,Chemical Vendors|Legacy Depositors,""
163197464,"(S,E)-N-(4-((3-Chloro-4-hydroxyphenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide","CS-0164260|(S,E)-N-(4-((3-Chloro-4-hydroxyphenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|(S,E)-N-(4-((3-Chloro-4-hydroxyphenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity pound(c)",483.900,C24H26ClN5O4,109.000,698.000,3.200,34,3,8,8,"InChI=1S/C24H26ClN5O4/c1-30(2)8-3-4-23(32)29-20-11-17-19(12-22(20)34-16-7-9-33-13-16)26-14-27-24(17)28-15-5-6-21(31)18(25)10-15/h3-6,10-12,14,16,31H,7-9,13H2,1-2H3,(H,29,32)(H,26,27,28)/b4-3+/t16-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)O)Cl)O[C@H]4CCOC4,SBWZLKKIQSAWPC-CWDCEQMOSA-N,(E)-N-[4-(3-chloro-4-hydroxyanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,483.1673320,483.1673320,0,1,0,1,1,0,1,1,0,0,0,0,"","",0,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company",Chemical Vendors,""
163197469,N-[3-chloro-4-[(3S)-oxolan-3-yl]oxyphenyl]-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,CS-0164277|N-(3-chloro-4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)-6-nitro-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine? (Afatinib Impurity pound(c),472.900,C22H21ClN4O6,121.000,671.000,3.900,33,1,9,6,"InChI=1S/C22H21ClN4O6/c23-17-7-13(1-2-20(17)32-14-3-5-30-10-14)26-22-16-8-19(27(28)29)21(9-18(16)24-12-25-22)33-15-4-6-31-11-15/h1-2,7-9,12,14-15H,3-6,10-11H2,(H,24,25,26)/t14-,15-/m0/s1",C1COC[C@H]1OC2=C(C=C(C=C2)NC3=NC=NC4=CC(=C(C=C43)[N+](=O)[O-])O[C@H]5CCOC5)Cl,WBYRBKSGKVBSKG-GJZGRUSLSA-N,N-[3-chloro-4-[(3S)-oxolan-3-yl]oxyphenyl]-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine,472.1149621,472.1149621,0,1,0,2,2,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197472,"4,7-bis[[(3S)-oxolan-3-yl]oxy]quinazolin-6-amine","CS-0164288|4,7-bis(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-amine? (Afatinib Impurity pound(c)",317.340,C16H19N3O4,88.700,400.000,1.200,23,1,7,4,"InChI=1S/C16H19N3O4/c17-13-5-12-14(6-15(13)22-10-1-3-20-7-10)18-9-19-16(12)23-11-2-4-21-8-11/h5-6,9-11H,1-4,7-8,17H2/t10-,11-/m0/s1",C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3O[C@H]4CCOC4)N,WYNRBGOGZKUHQG-QWRGUYRKSA-N,"4,7-bis[[(3S)-oxolan-3-yl]oxy]quinazolin-6-amine",317.13755610,317.13755610,0,1,0,2,2,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197474,"(3S)-4-[(3S)-4-chloro-3-hydroxybutoxy]butane-1,3-diol","CS-0164292|(S)-4-((S)-4-chloro-3-hydroxybutoxy)butane-1,3-diol? (Afatinib Impurity pound(c)",212.670,C8H17ClO4,69.900,112.000,-0.500,13,3,4,8,"InChI=1S/C8H17ClO4/c9-5-7(11)2-4-13-6-8(12)1-3-10/h7-8,10-12H,1-6H2/t7-,8-/m0/s1",C(CO)[C@@H](COCC[C@@H](CCl)O)O,PBKBEDMONRKXTA-YUMQZZPRSA-N,"(3S)-4-[(3S)-4-chloro-3-hydroxybutoxy]butane-1,3-diol",212.0815367,212.0815367,0,1,0,2,2,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
237034,Ethyl 4-(dimethylamino)-3-hydroxybutanoate,90227-57-9|ethyl 4-(dimethylamino)-3-hydroxybutanoate|ETHYL 4-DIMETHYLAMINO-3-HYDROXY-BUTANOATE|NSC40240|DTXSID90285021|NSC-40240|AKOS006373030|DB-157676|CS-0164316|E83374|ethyl 4-(dimethylamino)-3-hydroxybutanoate? (Afatinib Impurity pound(c),175.230,C8H17NO3,49.800,136.000,-0.200,12,1,4,6,"InChI=1S/C8H17NO3/c1-4-12-8(11)5-7(10)6-9(2)3/h7,10H,4-6H2,1-3H3",CCOC(=O)CC(CN(C)C)O,IWWLGURRMLSOCK-UHFFFAOYSA-N,ethyl 4-(dimethylamino)-3-hydroxybutanoate,175.12084340,175.12084340,0,1,0,1,0,1,0,0,0,0,0,0,"","",0,"",20050326,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|Accel Scientific|AKos Consulting & Solutions|AstaTech, Inc.|Aurora Fine Chemicals LLC|BLD Pharm|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|eNovation Chemicals|EPA DSSTox|J&H Chemical Co.,ltd|Molport|NextBio|RR Scientific|Starshine Chemical|SynHet - Synthetic Heterocycles",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
